shortness of breath, and hoarseness. This report aims to educate physicians and health care providers regarding secondary side effects resulting from this surgery. We present a case of a 61-year-old male patient who presented with secondary difficulty swallowing after undergoing ACDF in June 2016. The patient had dysphagia since surgery; furthermore, he had coughing, continuous clearing throat, aspiration, and occasional respiratory distress. Since 2016, the patient has been experiencing worsening shortness of breath, constant throat clearing, throat tightness, and dysphagia for solids and liquids. Following a barium swallow study, he demonstrated moderate oropharyngeal dysphagia characterized by poor laryngeal elevation/excursion, poor upper esophageal sphincter opening, delayed swallow trigger, and malfunction of epiglottis. Dysphagia, malfunction of epiglottis, aspiration, and respiratory distress are some of the complications of ACDF, with dysphagia being the most common. This report demonstrates the important association between dysphagia and ACDF. Therefore, it is essential that providers be aware of secondary complications after the surgery and research possible differences in management and outcomes.
A Bioabsorbable Fiducial for Head and Neck cancer Victoria Fischman (Presenter); Vladimir Ivanovic, MD; Scharukh Jalisi, MD
Objectives: This is the first study to evaluate a bioabsorbable fiducial for use in positive margins in head and neck cancers. Current practice uses titanium clips or other nonabsorbable materials; however, these have disadvantages that a bioabsorbable marker would improve on including permanence, artifact on imaging, and cost.
Methods: EchoMark is composed of L-lactide and ε-caprolactone and is currently approved by the Food and Drug Administration for use in vascular pedicle monitoring. A feasibility test was conducted placing the marker in an orange for computed tomography (CT) and in applesauce for magnetic resonance imaging (MRI) image acquisition. CT images, and T1, T2, and proton density-weighted MRI images were obtained. Standard CT and MRI parameters used in routine clinical practice were used.
Results: The CT and MRI images showed excellent delineation of EchoMark with all its margins well seen without adjacent artifact. EchoMark images appeared like that of air both on CT and MRI, surrounded by fluidlike appearance of the medium.
Conclusions: Intraoperative placement of a bioabsorbable fiducial provides a large benefit to head and neck surgeons and radiation oncologists. The pilot CT and MRI images show clinical utility for marking positive margins in the skull base or neck intraoperatively to guide future treatment and monitoring. Surgical bed appearance at the time when radiotherapy is planned should not produce any artifact near EchoMark, and there should be no inherent marker-related artifact. More research is needed to determine the appropriate size and shape Objectives: Human carbonyl reductase 1 (CBR1) plays key roles in the regulation of oxidative stress and tumor progression. However, the detailed mechanism and clinical correlation between CBR1 and tumor progression in head and neck squamous cell carcinoma (HNSCC) remain largely unexplored.
Methods: CBR1 messenger RNA (mRNA) expression was analyzed according to lymph node metastasis (LNM) status in patients with HNSCC from publicly available databases. CBR1 protein levels were measured and compared in HNSCC patient tissues, with or without metastasis, using immunohistochemistry (IHC). The invasive ability of HNSCC with modulated CBR1 expression was assayed using an invasion assay. Expression levels of epithelial-tomesenchymal transition (EMT) marker proteins were analyzed using immunoblotting.
Results: HNSCC patients with LNM showed lower expression of CBR1 than those without LNM. In addition, IHC in tissues indicated that patients with LNM had relatively lower levels of CBR1 in cancer tissue. Consistently, in in vitro invasion assay, we found that CBR1 inhibition using specific short interfering RNA treatment resulted in 2-fold to 3-fold increased invasion ability of HNSCC cell lines. Furthermore, we proved that depletion of CBR1 activated marker proteins participating in EMT signaling. CBR1 inhibition increased levels of intracellular reactive oxygen species (ROS) in HNSCC cells leading to upregulation of β-catenin, one of the main transcription factors that induce EMT-related genes.
Conclusions: Our findings suggest that CBR1 plays an important role in metastasis of HNSCC tumors via regulation of the ROS-mediated β-catenin activity and that CBR1 may be marker for progression of HNSCC to metastasis. 
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Objectives: To identify patients with oropharyngeal squamous cell carcinoma (OPSCC) treated with chemoradiation therapy (CRT) who may be at higher risk for posttreatment bleeding.
Methods: This was a retrospective case-control study. Patients with primary, advanced-stage OPSCC treated with CRT who sustained catastrophic posttreatment bleeds between 2016 and 2018 were identified. Patients were age-, stage-, and treatment-matched to patients who did not bleed. Patient characteristics including smoking status, medical comorbidities, need for gastrostomy tube, and amount of weight lost during treatment were recorded. A Head and Neck Fellowshiptrained radiologist performed a blinded analysis of pre-and posttreatment computed tomography scans using an American Joint Committee on Cancer descriptive classification system. Two-tailed t-tests were used to compare tumor and patient characteristics.
Results: Five patients who sustained bleeds (bleeders) and 5 matched controls (nonbleeders) were identified. There was no difference in pretreatment tumor morphology or vessel proximity to the tumor bed. Posttreatment imaging demonstrated ulcerated tumor beds in 100% of bleeders and 0% of nonbleeders. All nonbleeders (100%) demonstrated mucosalized tumor beds on posttreatment computed tomography. There were no significant differences in medical comorbidities, smoking status, or gastrostomy tube history. There was greater average weight loss in the bleeders as compared with nonbleeders: 18.5 vs 6.2 kg lost (P = .004), with 20.5% vs 9.4% pretreatment body weight lost (P = .01).
Conclusions: Patients with advanced-stage OPSCC treated with CRT who demonstrate significant weight loss during treatment and ulcerative tumor beds on posttreatment imaging may be at higher risk for catastrophic bleeding and may benefit from closer monitoring.
carotid Body Tumor Occurred with SdHA Germline Variants: Three Japanese cases Keisuke Yoshihama, MD (Presenter); Hiroyuki Ozawa; Hideki Mutai, PhD; Tatsuo Matsunaga; Kaoru Ogawa, MD Objectives: Carotid body tumor (CBT) is a rare disease that can be treated only by high-risk operation. Reports on its pathophysiology are scarce in the literature. About 5% of CBT is malignant, and these are difficult to cure completely. Familial CBT is observed in 10% of all cases, suggesting that genetic mutations may contribute to increased risk of CBT onset. Particularly representative of the above is SDHx gene variants. Dysfunction of succinate dehydrogenase (SDH) caused by mutations in the SDHx gene leads to pseudohypoxia in cells. Thus, pseudohypoxia is suspected in CBT pathophysiology. In this study, we searched and analyzed rare germline variants in CBT cases using a next-generation sequencer.
Methods: We extracted germline DNA from peripheral blood samples of patients with CBT between July 2015 and November 2017. Thirteen samples with no pathogenic or candidate pathogenic variants in SDHB/SDHD were identified by Sanger sequencing (HiSeq 2500 System, Illumina). For all suspected genetic variants, Sanger sequencing was performed on the exon regions.
Results: We found SDHA (NM_004168.3) heterozygous variants in 3 of the 13 CBT cases. These 3 variants were considered pathogenic according to the American College of Medical Genetics guideline. Relatively fewer reports have indicated SDHA genetic variation, compared with SDHC, SDHAF2, and TMEM127 variations, in head and neck paraganglioma. Additionally, there have been no reports of SDHA germline mutations in the Japanese population. We are planning to investigate possible somatic mutation in tumor-derived DNA to demonstrate tumorigenesis by Knudson's 2-hit theory assumed in CBT.
Conclusions: Three CBT cases of the 13 studied showed germline variants in SDHA. This is more frequent than that reported in other related diseases. To conclude, SDHA mutations may be involved in a disease-specific manner in the pathology of CBT.
A case of Bizarre Parosteal Osteochondromatous Proliferation of the Mandible
Austin Hong (Presenter); Thomas Heineman, MD; Steven Kupferman, MD, DMD; Keith E. Blackwell, MD; Jeffrey D. Suh, MD Objectives: Bizarre parosteal osteochondromatous proliferation (BPOP), also known as Nora lesion, is a rare tumorlike growth that commonly appears on the proximal tarsals of the feet. Less often, the lesion is found on the long bones or on the skull. To date, there has been 1 documented case of a Nora lesion on the mandible. We present a second occurrence of the lesion on the mandible of a 27-year-old woman. The goal of this study was to demonstrate the presentation, diagnosis, and treatment of an uncommon but distinct clinical entity that should be in the differential of all otolaryngologists.
Methods: A case presentation from an academic medical center is presented.
Results: A 27-year-old woman presented with a chief complaint of dental pain and looseness of tooth #29 accompanied by a large periodontal pocket. The patient reported a history of dental pain and gingival infections during mastication 18 months prior to presentation. A bony mass was found on a dental radiograph. The lesion was biopsied and tooth #29 was removed. The patient then underwent a complete excisional biopsy. Pathology demonstrated individual lacunae with nodular growths of cartilage with chondrocytes in addition to occasional minimal atypia. BPOP exhibits high rates of local recurrence, with more than half of patients showing signs of regrowth. Close surveillance is required for patients with BPOP. At last follow-up, the patient showed no signs of recurrence at 24 months.
Conclusions: BPOP, also known as Nora lesion, is a rare tumorlike growth and should be included in the differential of bony head and neck masses. The treatment is wide local excision, but given a high incidence of recurrence, patients should undergo regular surveillance.
Objectives: Liposarcoma is one of the most common softtissue sarcomas in the adult population; however, only about 40 cases of laryngeal involvement have been reported in the literature. Considering the infrequency of this disease presentation, specifics in the appropriate management remain unclear.
Methods: We present a recent case of a supraglottic liposarcoma including diagnosis and management of the disease and review of the literature.
Results: The reported patient initially presented with mild dysphagia, and indirect laryngoscopy in the office identified a submucosal lesion of the right AE fold. A computed tomography scan was performed, and the findings were consistent with a lipoma. Surgical biopsy was recommended; however, the patient deferred treatment until his dysphagia worsened and he started complaining of mild dyspnea. After obtaining the diagnosis, wide surgical excision was recommended.
Conclusions: Although liposarcoma seldom has metastatic potential, a high risk of local recurrence has been commonly reported in the literature. To prevent recurrence, wide surgical excision is recommended as a positive margin has been strongly correlated with tumor recurrence. Chemotherapy is currently not recommended because of the lack of sensitivity of liposarcomas to chemotherapeutic agents, but some studies have shown improved local control when radiation therapy is combined with surgical excision.
ceramic Reconstruction Implants and Three-dimensional Technology for Maxillofacial defects Denis Kulbakin, PhD (Presenter)
Objectives: To develop and clinically test the method for personalized maxillofacial reconstruction with the application of ceramic reconstructive implants.
Methods: The technique of virtual planning of the implants for maxillofacial reconstruction based on the patient's facial skeleton preoperative spiral computed tomography data was applied in the study, along with use of zirconium (ZrO ) ceramics (approved for bone arthroplasty and corresponding to the International Organization for Standardization standard). Implants from bioactive ceramics were created by three-dimensional printing method (reverse prototyping). Ceramic reconstructive implants were applied in 8 reconstructive maxillofacial area operations. All patients were diagnosed with malignant tumors of the maxilla and provided a consent to participate in the study. For reconstruction of the soft tissues of the premaxillary and cheek regions, in combination with a ceramic implant, 6 ALT flaps and 2 fibular flaps were used. Reconstruction was carried out in the delayed period (6-12 months) after resection of the maxilla.
Results: In all cases, the ceramic implants exactly fit to the area of reconstruction and the strength characteristics of the bone tissue. The observation period was 6 to 18 months. Good functional and cosmetic results were achieved in all cases. The use of ceramic reconstruction implants did not affect the postoperative period and the frequency of postoperative complications.
Conclusions: The developed reconstruction method involving individual application of ceramic implants for correction of maxillofacial defects is effective. The technique allows for restoring the maxillofacial defects with the achievement of maximum cosmetic and functional results. Objectives: Cancers of the abdominal or pelvic organ rarely metastasize to the cervical lymph nodes. Although it indicates distant metastasis, perceivable prolongation of survival or cure may be possible in selected cases. We sought to identify patients with cervical metastasis from cancers below the diaphragm and identify patients who may benefit from aggressive treatment.
Methods: From 2009 to 2017, patients with pathologically confirmed metastatic cervical lymph nodes originating from below the diaphragm were included for analysis. Patient demographics, cancer characteristics, treatment course, and clinical outcomes were analyzed.
Results: A total of 208 patients were identified. Left supraclavicular node (Virchow node) was the most frequently involved site. Irrespective of treatment, survival for uterine cervical and ovarian cancers was significantly longer than that of other primaries. Patients with isolated cervical metastasis (oligometastasis) had significantly longer median survival compared with patients with concomitant bone, lung, brain, and mediastinal metastases.
Conclusions: Although cervical metastasis from cancers of the abdominal and pelvic organ represent distant metastasis, patients with uterine cervical and ovarian cancers and primary and oligometastatic lesions may benefit from aggressive treatment. Prudent patient selection and further investigation are warranted.
P196
Otolaryngology-Head and Neck Surgery 161(2S) Presentation schedule is subject to change. The Official Program Abstracts supplement does not reflect changes made after August 9, 2019.
HEAd ANd NEck
aspiration (FNA) is obtained with a high sensitivity. Our aim is to present and evaluate our experience with cervical metastasis of unknown origin.
Methods: We present a retrospective study of patients diagnosed with metastases of unknown primary from the Registry of Head and Neck Tumors of the Ear, Nose, and Throat (ENT) Service at a university hospital from 2004 to April 2018. Demographic data (age and sex) and toxic habits (alcohol and tobacco) were collected. Diagnostic techniques and treatment guidelines followed the established protocol for primary tumors of unknown origin. If FNA of the adenopathy was positive for metastasis of squamous cell carcinoma and the tumor was not found after ENT exploration with nasofibroscopy and NBI, positron emission tomography/computed tomography (PET/CT) was performed. If PET/CT was also negative, panendoscopy and blind biopsies were performed. For the survival analysis, the Kaplan-Meier method was used.
Results: We have diagnosed 23 cases of metastasis of unknown primary cancer. Of these, 21 patients (91%) were male and 2 were female. According to the American Joint Committee on Cancer classification, 13 were N2a (56%), 2 N2b (9%), and 8 N3 (36%). In all patients, metastasis was diagnosed by FNA. With regard to histology, all were squamous cell carcinomas. Overall survival at 5 years in those patients with at least 5 years of follow-up was 51%. Our findings suggest that the size of N is the most important prognostic factor.
Conclusions: Cervical metastases of unknown primary, although infrequent, represent a diagnostic and therapeutic challenge for the otolaryngologist. Our objective is the study of cases treated in our hospital, presenting the diagnostic and therapeutic challenge for ENT.
cervico-mediastinal Teratoma in Adult:
Rare Presentation Blanca Leticia Del Carpio, MD (Presenter); Guillermo Stok, MD; Pablo Vallejo; Manuel Usandivaras; Franco Medrano
Objectives: To describe a rare case of an anterior mediastinal teratoma in an adult patient who presented with cervicomediastinal mass. Benign teratoma could be one of the differential diagnoses because it is a rare presentation.
Methods: A case report of a 26-year-old man attending Hospital Zenon Santillan in October with anterior cervical mass entered. On physical examination, a fluctuating and painful mass was observed at the base of the neck. He also had dysphagia and odynophagia.
Results: The patient had a fast-growing neck tumor. A computed tomography scan showed a cervical mass extending to the anterior mediastinum by compressing the trachea, jugular vein, and esophagus. The patient underwent a transverse cervicotomy and sternotomy, and a mass measuring 9.2 × 6.5 × 2 cm was resected.
Conclusions: We conclude that in adult patients who present with cervico-mediastinal mass, benign teratoma could be one of the differential diagnoses because it is a rare presentation. Results: The visceral flap was used exclusively for the reconstruction of the circumferential defect, and 35 cases (57.4%) were used for the salvage surgery. On the other hand, only 7 cases of MC/FCFF (17.1%) and 1 case of pedicled flap (4.0%) were used for circumferential defect reconstruction, whereas 16 (39%) and 17 (68%) patients in each group underwent salvage surgery. Despite these differences, there was no statistically significant difference in flap failure or fistula rate between the 3 groups (flap failure rate was 8.2% in visceral, 14.6% in MC/FCFF, and 8.0% in pedicled flap, while fistula occurred in 29.5%, 36.6%, and 52.0% in each group, respectively). In multivariable analysis, flap failure was associated with renal disease ([hazard ratio [HR] , 10.09) and hypoalbuminemia (HR = 12.11). Fistula rate was increased in salvage operation (HR = 2.85). However, the incidence of stenosis was affected by flap modalities, and 63.3% of stenosis occurred in the visceral group. MC/FCFF showed a greater protective effect than pedicled flap in stenosis (HR = 0.07).
Conclusions: Although hypopharyngeal reconstruction is quite challenging, it can be successful if we choose the appropriate flap reconstruction method. 
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Methods: A retrospective review of 157 patients diagnosed with metastatic NPC was conducted at a tertiary hospital in Singapore. Multivariable analysis was carried out to compare the overall and progression-free survival of patients with oligometastases vs widespread metastases, taking into account number of organ involvement as well as number of discrete lesions. A P value of less than .05 was considered significant.
Results: The patient demographics and disease characteristics were similar between patients with oligometastases and widespread metastases. Patients with oligometastatic disease (defined as 5 or fewer discrete metastatic lesions in a single organ) had a median overall survival of 24.8 months as compared with patients with widespread metastasis (12.8 months; P < .001). The median progression-free survival of oligometastatic NPC was also better than that of polymetastatic NPC (11.7 vs 7.3 months, P < .001).
Conclusions: Single-organ disease with less than 6 discrete metastatic lesions is a good indicator for metastatic load in patients. Patients with oligometastatic disease may achieve good metastatic survival and hence should be treated as aggressively as possible.
cold Atmospheric Plasma can Selectively Target Head and Neck Squamous cell cancer Jacob T. Cohen, MD (Presenter); Ziv Gil, MD; Yakov Slutsker; Yakov Krasik; Joshua Felsteiner; Yoav Binenbaum Objectives: Cold atmospheric plasma (CAP), with ion temperature close to room temperature, has tremendous potential in biomedical engineering and can potentially offer alternative treatment for abolition of cancer cells. A handheld flexible device to deliver CAP to the treatment site was designed and assembled by our team. The high-frequency pulse generator (RMS voltage of <1.2 kV) and low gas flow (0.3 ± 3 L per minute) allow this device to be operative inside the human body. The aims of our study were to characterize the CAP emitted from the device and to evaluate its efficacy in elimination of squamous cell carcinoma (SCC-CAL 27) cells in vitro and in vivo.
Methods and Results: Temperature of the CAP-treated target was 23°C to 36°C and was dependent on the voltage applied. Spectroscopy results indicated that excited OH-radicals were abundant both on dry and wet targets, placed at different distances from the plasma gun. An in vitro cell proliferation assay demonstrated that CAP treatment of 60 seconds resulted in significant reduction in proliferation of all cancer cell lines tested. In vivo, we treated SCC-CAL 27 tumors in nude mice. Tumor volume was significantly reduced in CAP-treated tumors relative to controls, and high dose per fraction was more effective than low dose per fraction treatment. Importantly, pathologic examination revealed that normal skin was not harmed by the CAP treatment.
Conclusions: This preliminary study demonstrates the efficacy of flexible CAP delivery system against squamous cell carcinoma progression both in vitro and in vivo. It is envisioned that adaptation of CAP technology can provide a new modality for the treatment of solid tumors. Objectives: Using optical imaging with near-infrared (NIR) fluorescent dye to aid in achieving tumor-free margins during transoral robotic surgery (TORS) is currently being explored. In this study, we aimed to compare 2 camera systems: the FIREFLY platform, a system built into the da Vinci robot, and the Visionsense Iridium system, a commercially available NIR visualization platform.
Methods: From August 2017 to the present, patients undergoing TORS resection of oropharyngeal lesions were included. Each patient was injected intravenously with indocyanine green (ICG) dye the day prior to surgery. Both the FIREFLY and Visionsense Iridium camera systems were used in real time during surgery to create a superimposition of visible and NIR light displays of the primary lesion. Presence of fluorescence, definition of lesion, and clarity were compared between the 2 systems.
Results: Six patients were included. The FIREFLY system did not show fluorescence in 4 of 6 cases and showed only minimal fluorescence in the remaining 1 case with poor definition of the lesion margins. The Visionsense Iridium system showed marked fluorescence in 5 of 6 cases (83.3%), with good definition of margins in 4 cases. The Visionsense system was also able to identify a tumor that the surgeon was unable to visualize with white light in 2 cases.
Conclusions: When using NIR imaging with ICG dye for visualization of oropharyngeal tumors during TORS, the dedicated NIR imaging system Visionsense Iridium outperforms the FIREFLY system built into the da Vinci robot. Methods: After approval from our institution's institutional review board, a retrospective case review was carried out at a single tertiary hospital. Chart review was performed on adults undergoing free-flap reconstruction for head and neck cancer between 2015 and 2017 to obtain patient demographics, procedures, transfusions during hospitalization, and complications within 90 days. Deidentified data were entered into a REDCap database. Statistical analysis was performed with GraphPad Prism 7.0.
Results: Transfusions were associated with increased risk of complications. Patients who received at least 1 transfusion were more likely to develop pneumonia (13.3% vs 3%, P < .05), Locations of distant metastasis were bone (6 cases), lung (6 cases), and liver (4 cases; includes overlapping).
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Results: Chemoradiation for primary and neck disease and systemic chemotherapy were performed in all cases. For distant metastatic disease, surgery (lung: 2 cases, bone: 1 case, liver: 2 cases) or (chemo) radiation (bone: 5 cases, lung: 1 case) was performed against the metastatic lesions. The disease control rate for distant metastasis was 57%. The 3-year overall survival was 69%, and the 3-year disease-free survival was 38%.
Conclusions: Although our study is of a small number, our results suggest that surgery or radiation therapy for distant metastatic disease may still be an effective treatment option for stage IVB NPC. The age distribution of our patients was low, which made it possible for comprehensive, individual intensive treatment. In the era of molecular targeted drugs, combination therapy including cetuximab or immune checkpoint inhibitors is recognized as a primary treatment option for stage IVB NPC. However, individual treatment strategies should be recognized and discussed while considering the patients' quality of life. Methods: We performed a retrospective review of patients treated for T1/T2 p16+ OPSCC at a single academic tertiary care institution from January 2013 to December 2015. Patients presented at MDTB were staged radiographically with positron emission tomography and contrast-enhanced computed tomography and separated into 2 cohorts based on the addition of a fellowship-trained TORS surgeon, representing a shift in treatment from primarily chemoradiotherapy (CRT) to either definitive CRT or TORS with adjuvant therapy.
Results: A total of 59 patients were included cohort 1, which represented the period prior to the introduction of TORS; 71 patients were included in cohort 2, whose strategy included a surgical option. Objectives: Squamous cell carcinoma (SCC) of the face/ scalp generally has a favorable outcome. However, patients with delayed regional metastasis from scalp/facial SCC do very poorly. Historically, prophylactic treatment of the neck for T1-T2 face/scalp cancers has not been recommended. This study aims to determine predictors of delayed regional metastases in early-stage cutaneous SCC of the head and neck.
Method: We retrospectively analyzed medical records of patients diagnosed with regional metastasis of SCC of the scalp/face at least 6 months after their diagnosis of the primary cutaneous SCC at the University of Tennessee between 2012 and 2018.
Results: A total of 62 patients with SCC of the face/scalp were diagnosed and treated for delayed cervical metastasis during a 6-year period. The overall male-to-female ratio was 5 to 0. Areas affected were the scalp, cheeks, forehead, nose, and ears. No patient had neck lymph node metastases at presentation for his or her scalp/face cancer. The presence of perineural invasion (PNI) in the primary tumor was the only
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Conclusions: In our review, PNI was the one factor predictive of delayed regional metastasis. Prophylactic treatment of the neck in patients with T1-2 scalp/face cancers with PNI should be strongly considered. Objectives: The current literature describing periocular melanoma, a very rare entity, is limited to case reports and small single-institutional studies. We present the first large, multiinstitutional population-based study of periocular melanoma and aim to provide a better understanding of the epidemiology of this malignancy.
Methods: The Surveillance, Epidemiology, and End Results (SEER) database was queried for all cases of melanoma of the eyelid from 1975 to 2015. Demographic characteristics and incidence trends were analyzed.
Results: A total of 1344 cases of periocular melanoma were identified in the database. The mean age at diagnosis was 67.8 years. There was a slight male predominance (52.8% vs 47.2%). Periocular melanoma occurred overwhelmingly in white patients (90%), compared with Hispanic (6%), Asian/ Pacific Islander (0.9%), American Indian/Alaska Native (0.3), and Unknown (2.6%) patients. By geographic location, most cases occurred on the Pacific Coast (46.4%), followed by East (34.7%), Northern Plains (10.8%), and Southwest (8%). The overall incidence of melanoma in situ was 0.066 per 100,000 people, whereas that of malignant melanoma was 0.076 per 100,000 people. The incidence of periocular melanoma significantly increased across the study period, with an annual percentage change of 1.164% (P < .05).
Conclusions: We present the largest cohort of periocular melanoma. The mean age of diagnosis was 67.8 years. Most cases were male, white, and lived on the Pacific Coast. The incidence of periocular melanoma has been significantly rising over the past 40 years.
disparities in Global Head and Neck cancer Burden and Surgical Management
Rolvix Harlan Patterson (Presenter); Jennifer Siu; Alice Tang, MD, ScM; Blake C. Alkire, MD, MPH Objectives: Head and neck cancers (HNCs) are the ninth most common cancer. They disproportionately burden lowincome countries (LICs), where radiotherapy and chemotherapy are often absent, meaning that surgery is the primary mode of curative treatment. Here, we identify global trends in HNC mortality-to-incidence ratios (MIRs), an indicator used to assess cancer care disparities and survival, as they relate to surgical workforce.
Methods: Incidence and mortality data were gathered for 195 countries from the Global Burden of Disease (GBD) 2017 study, and MIRs were calculated. Surgical, obstetric, and anesthesia (SOA) provider density was used as an indicator of surgical workforce level. Countries were classified using World Bank income groups as LIC, lower-middle-income (LMIC), upper-middle-income (UMIC), and high-income (HIC) countries. Analysis was performed using linear regression with MIR as the dependent variable and log-transformed SOA as the independent variable.
Results: Disparities in HNC MIR existed between income groups (means: HIC 0.56 ± 0.03, UMIC 0.71 ± 0.02, LMIC 0.83 ± 0.03, LIC 0.96 ± 0.04, P < .0001, R 2 = 0.83). HNC MIR also correlated significantly with SOA density after adjusting for income group (β = −0.05, P < .001). Finally, GBD Foresight mortality data show that the inequality in disease burden will increase by 2040 as LICs, LMICs, and UMICs will face a combined 186% increase in HNC mortality compared with a 114% increase in HICs.
Conclusions: HNC mortality disproportionately burdens LICs. Countries with a limited SOA workforce, which is essential for HNC management, have higher MIR regardless of income group. Predictions indicate that HNC mortality disparities will grow substantially by 2040. Objectives: Periprosthetic leakage is a frequent complication of voice prostheses. It is sometimes a challenge for head and neck practitioners. We showed that the Blom and Singer large esophageal and tracheal flanges voice prostheses can be useful tools to manage periprosthetic leakage. This prosthesis was released on the French market for a few years. It is time to evaluate the lifetime of this new prosthesis.
Methods: This work is a prospective study from November 2010 to December 2018. A total of 258 prostheses were placed with success on 58 patients with enlarged esotracheal fistula. In this study, the average lifetime of the prothesis is about 98 days.
Results: Some recent studies reported the classic prosthesis lifetime, but the prostheses with large flanges were not included in these studies to our knowledge. The lifetime observed in our work with this specific prosthesis was not significantly different from results published elsewhere. The better lifetime found in our work was probably due to the systematic use of the introduction kit of these prostheses (with gel cap), which is known to be less traumatic for the fistula. These results are in accordance with our clinical findings. The change of large flanges prosthesis was performed for per-prosthetic leakage and never for a new periprosthetic leakage.
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Conclusions: Our results showed that the lifetime of the Blom and Singer large flanges voice prosthesis is similar to that of the other prostheses that have been published. The large flanges are not a factor of premature aging for this type of prosthesis. Our study has confirmed that this device is interesting to manage periprosthetic leakage in the long run.
Effect of Postoperative Radiotherapy on Survival for pT3N0 Laryngeal cancer
Filipe Andre Correia, MD (Presenter); Pedro Montalvao, MD; Rui Fino; Sara Ramalho, MD; Miguel Magalhaes, MD Objectives: To compare disease-free survival (DFS) rate and overall survival (OS) rate between patients treated with and without postoperative radiotherapy (PORT) for pT3N0 laryngeal cancer. Search for an association between patient, histologic and treatment characteristics, and recurrence and death.
Methods: In December 2018, we conducted a retrospective study, including patients diagnosed with pT3N0 laryngeal cancer treated with total laryngectomy between 2008 and 2017 in a single tertiary center. Collected and analyzed data included patient, tumor and treatment characteristics, and time to recurrence and death. Univariable and multivariable analysis were used to determine factors associated with radiotherapy, recurrence, and death.
Results: A total of 79 patients met all inclusion criteria (96.2% were male). Of these, 54.4% had transglottic tumors and a bilateral neck dissection was performed in all primary laryngeal tumors; 68.4% of patients were treated with PORT, with higher rates in younger patients, with no previous head and neck cancer, nonglottic tumors, and lower margins (P < .05). Perineural invasion was evident in 10% of specimens, and it was associated with death on follow-up (P < .05). The 5-year DFS rate was 81%, and the 5-year OS rate was 70%. Survival curves were similar between PORT and non-PORT groups. There was no statistically significant difference in death and recurrence rates regarding the remaining studied variables. Median time to recurrence and death was 15 and 24 months, respectively, and it was inferior with no adjunctive treatment (P < .05).
Conclusions: PORT in patients with pT3N0 tumors treated with total laryngectomy had no influence on their OS and DFS, although it appears to be associated with an increase in time to recurrence and death.
The Effect of Terpenoids on Oral cavity Squamous cell carcinoma
Rachel Kominsky, MD (Presenter); Zhimin Feng, PhD; Lechuang Chen, PhD; Jeanie Sozansky Lujan, MD; Ge Jin, PhD
Objectives: To evaluate the effect of terpenoids, naturally occurring compounds found in our foods and environment, on oral cavity cancer cells through in vitro and in vivo studies.
Methods: Studies were conducted in a basic science laboratory from October 2018 to December 2018 to evaluate the effect of terpenoids compared with cisplatin on oral cavity squamous cell carcinoma. In vitro studies included proliferation assays, apoptosis assays, cell cycle analysis, and flow cytometry. In addition, one of the terpenoids, limonene, was selected to be studied in a mouse model. In nude mice, cells from an oral cavity squamous cell carcinoma line were injected into the mouse's ventral surface to induce tumor development. Then, limonene was injected intratumorally to analyze its effect on tumor growth as well as its effect on the tumor microenvironment. The mice were killed to analyze the size of the tumors as well as the tumor microenvironment with flow cytometry.
Results: In vitro, proliferation studies showed that limonene was able to inhibit the growth of cancer cells without inhibiting the growth of normal human cells. Cisplatin, however, significantly inhibited the growth of cancer cells as well as normal cells. In the mouse model, it was found that the tumors treated with limonene had decreased volume and decreased growth rate when compared with the tumors in the untreated or control group.
Conclusions: Limonene exhibits antineoplastic activity against oral cavity cancer cells but does not exhibit cytotoxic effects on normal cells. Data from mouse experiments show that when tumors of oral cavity cancer cells are treated with the naturally occurring compound limonene, the tumors do not grow as large or as rapidly as untreated tumors. Objectives: To examine the diagnostic accuracy and incidence of endocrine mucin-producing sweat gland carcinoma (EMPSGC) locoregional metastasis, as well as provide clinicians with data to improve the care of future patients, while presenting a novel case of EMPSGC with metastasis to the parotid gland.
Endocrine Mucin-Producing Sweat
Methods: A systematic review was performed following Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines using PubMed-NCBI, Scopus, and Google Scholar. The search term Endocrine Mucin-producing Sweat Gland Carcinoma was used to identify confirmed cases of EMPSGC published up to December 2018. Tumor pathology, metastasis and recurrence data as well as demographic, diagnostic, treatment, and follow-up data were collected and analyzed. Data pertaining to our case were obtained via review of electronic medical records.
Results: A total of 34 publications with 109 cases of EMPSGC were included. The mean age at presentation was 67.1 years (range = 29-88 years), and 84% (92/109) of tumors were located on the eyelid or canthus. In 66% (95% confidence interval = 49.86-80.96) of cases, initial pathological diagnosis of EMPSGC was made correctly. When described, resection was by excisional biopsy in 33% (10/30) of cases, wide surgical excision in 33% (10/30), and by Mohs micrographic surgery in 33% (10/30). Of the cases followed for recurrence over a mean follow-up period of 21.3 months, EMPSGC recurred in 8% (4/48) of cases. No other cases had reported metastasis.
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Conclusions: We present a comprehensive review of reported EMPSGC cases as well as a novel case, which demonstrates the ability of EMPSGC to metastasize to regional lymph nodes. Additional analyses comparing types of surgical treatment, diagnostic modalities, and clinicopathologic features will be presented to improve future diagnostic and therapeutic options for pathologists, dermatologists, and otolaryngologists-head and neck surgeons.
Endoscopic Surgery for Tumors of ParaNasal Sinuses: An Institutional Experience Rajat Jain, MS (Presenter); Ravi Sankar Manogaran, MS, DNB; Pearly Pattayil Keerangat; Arulalan Mathialagan; Surendra Singh Baghel; Amit Kumar Keshri Objectives: Paranasal sinus (PNS) tumors are benign/malignant, accounting for 3% to 4% of head and neck cancers. Surgery is the mainstay treatment of benign tumors, whereas surgery with/without chemoradiotherapy is better for malignant lesions. With the advent of high-definition endoscopy, high-speed drill, powered instruments, and navigation systems, all benign lesions and most malignant lesions are amenable for endoscopic resection without compromising safety and efficacy of surgery. Endoscopic surgery for tumors of the nose and PNS is safe and effective. The desired results can be obtained with minimal morbidity and lesser hospital stay and good cosmesis.
Methods: Retrospective study was conducted at a tertiary care institute in India. A total of 72 patients (49 male and 23 female) were operated on using the endoscopic/open approach between 2008 and 2018 and data reviewed. Preoperative computed tomography, magnetic resonance imaging, and biopsy were performed in all cases (juvenile angiofibroma and nasopharyngeal carcinoma were excluded from the study). Follow-up ranged from 6 to 60 months, with a mean follow-up of 14 months.
Results: There were a total of 26 benign and 46 malignant tumors. In benign tumors, inverted papilloma (n = 15) was the most common finding, followed by plasma cell proliferative disorder (n = 2). In malignant tumors, adenoid cystic carcinoma (n = 9) was the most common followed by adenocarcinoma (n = 5) and sinonasal undifferentiated carcinoma (n = 5).
Conclusions: Endoscopic surgery of tumor of the nose and PNS tumors is safe and effective in selected cases. Larger series and long-term follow-up will give more credentials to endoscopic surgery of these tumors. Endoscopic surgery is not suitable for cases with facial skin involvement, gross extension to the anterior cranial fossa, and squamous cell carcinoma of the maxilla with gross bony destruction. Objectives: To evaluate clinicopathologic characteristics of delayed recurrence after nodal recurrence following negative sentinel lymph node biopsy (SLNB) for melanoma, known as false-negative (FN) SLNB, in cutaneous head and neck melanoma (HNM).
Evaluation of False-Negative Sentinel Lymph
Methods: A retrospective single-institution cohort study was performed of 356 patients who underwent SLNB for HNM from 1997 to 2007. The primary outcome measure was radiologic or clinical diagnosis of delayed recurrence.
Results: Of the previously reported 281 cases of negative SLNB, 18 (6.4%) developed regional recurrence, with mean time to recurrence of 3.12 ± 3.36 years. Primary sites involved were cutaneous face/neck (n = 11), scalp (n = 4), and ear (n = 3). Pathologic characteristics were notable for 12 cases of superficial spreading melanoma and aggressive features such as mitoses (n = 16), ulceration (n = 3), and angiolymphatic invasion (n = 2). SLNB findings included a total of 1 to 3 nodes removed (median 2) from the following nodal basins: cervical (n = 15), parotid (n = 2), and preauricular (n = 1). In terms of recurrence site, nearly half of patients recurred in the same basin as a prior negative sentinel node, with most patients recurring in the ipsilateral neck (n = 12). The remainder of recurrences were in the parotid (n = 4) and preauricular regions (n = 2). All underwent salvage lymph node neck dissection, with 15 cases of positive nodes (median 4 nodes) identified, with 6 having extracapsular extension and 6 cases of resulting CN weakness. Ultimately, 8 cases (44%) developed distant metastases (3 liver, 3 lung, 1 brain, 1 axilla) an average of 2.28 ± 2.49 years from the regional recurrence diagnosis.
Conclusions: Increased nodal surveillance after FN SLNB should be considered, given the risk of distant metastases.
Evaluation of Prognostic Factors in Oral Tongue carcinomas Ching-Yi Yiu, MD (Presenter); Hui-Chen Hsu
Objectives: Oral cancer is a significant health burden in areas with high betel nut consumption, especially Southeast Asia and Taiwan. Besides the TNM system, an other stratification classification system based on pretreatment systemic hematological counts and ratios is used to predict the prognosis and recurrence of various head and neck cancers. We aimed to retrospectively review these prognostic factors in our oral tongue cancer patients.
Methods: Between January 2012 and December 2016, 86 patients with previously untreated oral tongue cancer at our department were reviewed. Forty-seven patients (54.7%) were T1, 28 (32.6%) T2, 9 (10.5%) T3, and 2 (2.3%) T4. Concerning N stage, 59 (68.6%) were N0, 9 (10.5%) N1, and 18 (20.9%) N2. The prognosis based on age (<45 or >45 years), sex, T stage (T1/T2 or T3/T4), N stage, platelet count (≥3.0 × 10 9 per L or <3.0 × 10 9 per L), and neutrophil-to-lymphocyte ratio (NLR; <3 or ≥3) was evaluated.
Results: A total of 15 patients had platelet count ≥3.0 × 10 9 per L and 71 patients <3.0 × 10 9 per L. As many as
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26 patients had NLR ≥3 and 60 patients NLR <3. The 3-and 5-year overall survival (OS) rates were 69.1% and 63.0%, respectively. In univariate analysis, OS was significantly associated with T stage (P = .012) and N stage (N1 with N0, P = .002; N2 with N0, P < .001). However, age (P = .721), sex (P = .202), platelet count (P = .532), and NLR (P = .137) were not significantly associated with OS. The multivariable analysis showed that only N stage was significantly associated with OS (P = .033).
Conclusions: Oral tongue carcinoma is the most common form of oral cancer in areas with high consumption of tobacco and betel nuts. Systemic hematological counts and ratios were analyzed to predict head and neck cancer prognosis. The cutoff value of these predicators still needs further evaluation in the future studies.
The Evolving Landscape of Laryngeal cancer: Trends in Treatment and Survival
Richard D. Bavier (Presenter); Nicole I. Farber; Joseph S. Weisberger; Soly Baredes, MD; Richard C. Park
Objectives: The objective of this analysis is to determine the current state of survival, diagnosis, and patterns of management in laryngeal cancer.
Methods: This retrospective study analyzes squamous cell carcinoma cases of the larynx (n = 70,007) using deidentified oncological data from the National Cancer Database diagnosed from 2006 to 2014. Data on demographics, management, clinicopathology, and survival were obtained from the selected cases and subsequently analyzed.
Results: The cases included for analysis were primarily glottic (48%), supraglottic (37%), or subglottic (2%), and were stage 1 (32%), stage 2 (17%), stage 3 (19%), or stage 4 (29%) at time of diagnosis. Our analysis identifies an upward trend in overall survival (OS) for laryngeal cancers, with a 1.5% increase in 1-year OS and 2.2% increase in 5-year OS. This was largely due to a 4.4% increase in 5-year OS in supraglottic cancer and 2.5% increase in 5-year OS in glottic cancer. Patterns of initial management across this same period indicated an increase in surgical treatment (2006: 39.1%; 2014: 42.6%) , with the largest increase in patients receiving surgery alone (2006: 9.0%, 2014: 12.0%). No trend was found in primary site, stage at diagnosis, race, or histologic grade.
Conclusions: An increase in OS corresponded to more surgical management of patients with laryngeal cancer.
Facial Nerve decompression for Parotid Tumors at the Stylomastoid Foramen
Joseph Broderick (Presenter); Ved Tanavde; C. Matthew Stewart, MD, PhD; David W. Eisele, MD; Francis X. Creighton, MD Objectives: To assess the outcomes of mastoidectomy with facial nerve decompression during parotidectomy for benign parotid tumors adjacent to the stylomastoid foramen.
Methods: A retrospective review was conducted of 125 patients who underwent mastoidectomy and facial nerve decompression in conjunction with parotidectomy. Patients with malignant pathologies, recurrent tumor, or those with tumors not located at the stylomastoid foramen were excluded. Outcomes, including tumor spillage and immediate as well as long-term facial nerve outcomes, were assessed. Imaging reports were reviewed to assess the location of the parotid lesion.
Results: Twelve patients from 2012 to 2018 with benign lesions at the stylomastoid foramen underwent parotidectomy that ultimately required mastoidectomy and facial nerve decompression. Of these patients, 10 had pleomorphic adenoma and 2 had benign cysts. The average operative time was 341.6 minutes (standard deviation [SD] = 33.6 minutes), and the average length of stay was 0.67 days (SD = 0.78 days). No patient required free-flap reconstruction, and there were no postoperative complications. Four patients had incomplete facial weakness immediately postoperatively. All 4 of these patients recovered to HBI without synkinesis. The other 8 patients had normal facial function postoperatively. One case had intraoperative spillage of tumor, and no case had recurrence. Mean follow-up was 486.8 days (SD = 476.1).
Conclusions: For tumors located at the stylomastoid foramen, mastoidectomy and facial nerve decompression can safely aid in performing parotidectomy.
Functional Outcome of Free Jejunal Transfer Reconstruction
Takashi Kitani, MD (Presenter); Naohito Hato, MD Objectives: Free jejunal transfer (FJT) is a standard method of reconstruction after total pharyngo-laryngo-cervical esophagectomy (TPLE). Head and neck surgeons, plastic surgeons, and digestive surgeons perform TPLE and FJT in cooperation with each other; however, there is a diversity in procedures, and the responsible range among each department. Therefore, the operation time and postoperative complications are different in each institution.
Methods: To clarify problems of FJT in our institution, we investigated 18 cases retrospectively who were undergoing FJT after TPLE for hypopharyngeal or cervical esophageal cancer between 2008 and 2018 in our institution.
Results: A total of 13 male and 5 female patients were enrolled. Three patients received salvage surgery for recurrence after chemoradiotherapy, and 3 patients had a history of radiotherapy for other head and neck cancers. Seven patients received adjuvant radiotherapy or chemoradiotherapy. Since 2008, in FJT, head and neck surgeons anastomose oral side, plastic surgeons anastomose vessels, and digestive surgeons anastomose the anal side in our institution. The oral side was anastomosed end to end by hand stitches, and the anal side was end to side using an automatic anastomosis instrument. The average operation time was 655 minutes, and the average amount of blood loss was 372 mL. All patients became orally ingestible on average 11 days after surgery, but in 5 cases, balloon dilation was required because of due to anastomotic stenosis. Four of 5 patients with anastomotic stenosis were treated with adjuvant radiotherapy. All stenoses were on the
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anal side and all of them became orally ingestible after balloon dilation. We considered the problems and the remedy of FJT in our institution.
Giant dentigerous cyst: Evaluation and Treatment with Midface degloving
Susan Kurian, MD (Presenter); Kevin A. Moore; Edward Milligan; Ameya A. Asarkar, MD
Objectives: To present a unique case of giant dentigerous cyst crossing midline, a finding not previously reported in the literature. We present this case to increase awareness of this rare entity so patients can be treated appropriately.
Methods: A 62-year-old man presented with an 8-month history of a progressively growing lesion causing midface protuberance. The patient previously had complete dental extractions and was clinically edentulous. Computed tomography imaging showed a large cystic mass associated with an unruptured maxillary tooth with extensive bony remodeling of the anterior maxilla, hard palate, and inferior nasal cavity and extending to the ventral margin of left maxillary sinus. After surgical treatment, pathology was consistent with a benign dentigerous cyst.
Results: Surgical intervention was planned to use a midface degloving approach with sublabial incision, nasal transfixion incision, and nasal aperture incisions. The mass was noted to be adherent to bone and filled with thin fluid. After removal, a 4 × 6 × 3-cm 3 cavity was present above the hard palate with posterosuperior displacement of inferior nasal structures due to mass effect. After surgical resection, the patient was followed with no recurrence and good cosmesis.
Conclusions: Dentigerous cysts are associated with unerupted teeth and are the most common developmental cysts of the jaw. These cysts are usually asymptomatic but can displace teeth on sufficient growth. This is a rare case of giant dentigerous cyst crossing the midline and causing extensive bony remodeling requiring a more invasive approach for surgical resection. Complete resection with clinical follow-up is recommended. For head and neck surgeons, identification of expanding dentigerous cyst is essential in guiding intervention.
Glomangiopericytoma: Improved Surgical Resection through Endoscopic Approach
Allen H. Young, MD (Presenter); Oluwafunmilola T. Okuyemi, MD Objectives: Glomangiopericytomas are rare, low-malignantpotential tumors derived from modified smooth muscle cells surrounding capillaries. They encompass less than 0.5% of sinonasal tumors and less than 1% of vascular tumors. There is a female predominance with peak age in the seventh decade. Although traditional treatment has been open resection, endoscopic approach shows promise in decreasing morbidity, increasing visualization, and improving surveillance.
Methods: A 46-year-old man presented with left nasal glomangiopericytoma on biopsy. On endoscopic examination, a vascular tumor filled the entire nasal cavity with involvement of the ethmoid and sphenoid sinuses. The origin of the tumor was found at the cribriform plate, near the insertion of the middle turbinate to the skull base. He subsequently underwent endoscopic resection of the mass with negative margins.
Results: Our unique case presented a patient outside the usual demographic for this tumor with extension to the cribriform plate. Immunohistopathology confirmed glomangiopericytoma with spindled cells in whorl-like pattern around branching blood vessel and positive staining for vimentin and factor XIIIA. Although open approaches have traditionally been used for resection, our endoscopic technique demonstrated decreased morbidity through improved visualization of the tumor and its insertion at the cribriform plate, which allowed for adequate resection and protection of the lamina papyracea and ethmoidal artery. Furthermore, the endoscopic approach allowed for consistent surveillance for tumor recurrence.
Conclusions: Glomangiopericytomas are rare, vascular sinonasal tumors. Endoscopic resection can minimize morbidity through improved visualization and facilitate subsequent surveillance.
Glossal Angioleiomyoma: Rare case with Negative Hormonal Immunohistochemistry Allen H. Young, MD (Presenter); Oluwafunmilola T. Okuyemi, MD Objectives: Angioleiomyoma is a benign, vascular variant of leiomyoma. They are extremely rare in the otolaryngology setting and account for only 0.42% of all soft-tissue lesions in the oral cavity, and only 0.065% of leiomyomas are in the oral cavity. Immunohistopathology is the gold standard to confirm diagnosis. Although mechanical trauma, chronic inflammation, and venous stasis are known etiologic factors, hormonal involvement has been proposed. Existing cases show strong expression of sex hormones receptors in the tumor cell nucleus, suggesting an influence on growth and degeneration.
Methods: Case report. We present a 54-year-old man with a 2-cm right anterolateral tongue mass. Biopsy showed angioleiomyoma, and he underwent a partial glossectomy. Histopathology showed submucosal lesion composed of blood vessels and smooth muscle. The specimen had negative margins with no signs of malignancy.
Results: In our case, we confirmed glossal angioleiomyoma on immunohistochemistry with the presence of smooth muscle cells on positive smooth muscle actin and desmin stains. Negative CD34 and S100 ruled out schwannoma and neurofibroma. Negative MART-1 and HMB-45 ruled out angiomyolipoma. Interestingly, our specimen had negative progesterone and estrogen receptor staining. The role of sex hormones in angioleiomyoma development has been described in studies showing positive staining in leiomyomas from the nasal cavity and buccal space. Our case demonstrates a negative hormone receptor expressing oral angioleiomyoma, countering the notion that sex hormone may influence oral angioleiomyoma.
Conclusions: We report a rare case of an oral cavity glossal angioleiomyoma with negative hormonal immunohistochemistry
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stains. This challenges the existing correlation between sex hormones and angioleiomyoma development. Methods: A retrospective chart review was conducted of 3 patients with BOT tumors who underwent in-office ultrasound-guided transcervical FNA at a single institution between 2016-2019.
In-Office ultrasound-Guided Transcervical
Results: Three patients with BOT tumors ≥3 cm were identified. There was no cervical adenopathy in 2 patients whereas FNA of a cervical lymph node was inconclusive in Patient 3. Patient 1 and 2 had multiple medical comorbidities rendering them at high risk for general anesthesia. In the third patient, the BOT tumor obscured visualization of the glottis. Although the patient was not having airway symptoms, this would have precluded intubation and potentially required tracheostomy under local anesthesia to proceed with direct laryngoscopy and biopsy. All patients underwent successful in-office ultrasound-guided transcervical FNA with results showing squamous cell carcinoma. None of the patients experienced any complications related to the procedure.
Conclusions: In-office ultrasound-guided transcervical FNA can be used for diagnosis of BOT lesions that are evident on ultrasound. This is particularly beneficial in cases in which general anesthesia is considered high risk. In addition, one of our patients was able to safely continue anticoagulation for the procedure and another was able to avoid tracheostomy. This technique is also cost effective as it avoids the expenses associated with operative intervention. Methods: The study included patients who underwent parotid surgery (superficial parotidectomy, partial superficial parotidectomy, and total parotidectomy) during 2014 to 2017. Surgical records were retrieved, and residents who participated in the operation were asked to score their training during the procedures with scores from 0 to 3 (0 being no training, 1 = skin incision and/or suturing, 2 = elevation of flaps, and 3 = facial nerve dissection). Results were correlated with findings of FNAC.
Is
Results: Of 239 patients who underwent parotid surgery, 143 had previous FNA examinations and were included in the study. A total of 117 had a histological confirmation of benign tumor (56 pleomorphic adenoma and 35 Warthin tumor) and 26 malignant. FNAC showed a total sensitivity of 96.58% (76.08% for Warthin tumor and 91.80% for pleomorphic adenoma). Twelve current and former residents were asked to score their surgical training during those procedures. Total best scores were significantly correlated with a preoperative diagnosis of Warthin tumor, followed by pleomorphic adenoma. A preoperative diagnosis of a malignant tumor was correlated with poor resident training scores.
Conclusions: These results indicate that the low possibility of recurrence that is anticipated in tumors such as Warthin provides the attending surgeon more confidence to teach the resident. This is a further indication of performing FNAC, especially in institutions with a resident training program. Objectives: We sought to identify key prognostic indicators in patients undergoing salvage total laryngectomy to facilitate evidence-based preoperative and postoperative patient counseling.
Methods: A retrospective review is presented of 57 patients undergoing salvage total laryngectomy for recurrent laryngeal squamous cell carcinoma between 2002 and 2015. Endpoints retrieved encompass patient demographics and tumor characteristics, which were analyzed against local failure (LF), regional failure (RF), and survival. Fisher test, Student test, and/or log rank tests were used to identify significant relationships. Survival analyses were performed with Kaplan-Meier estimates. A P value <.05 was used to define statistical significance.
Results: Overall survival averaged 54 months (27 deaths), with disease-specific survival (DSS) averaging 68 months (n = 19), LF averaging 54 months (n = 22), and RF averaging 79 months (n = 8). Lymphovascular invasion (LVI) demonstrated a significant reduction in DSS (P = .018), disease-free survival (DFS; P = .042), and time to LF (P = .010). Positive and <5-mm margins exhibited a significant decrease in DFS (P = .024 and P = .015), with positive margins also showing a significant decrease in time to LF and RF (P = .002 and P = .016). cT4 and pT4 staging demonstrated a significant reduction in DFS (P = .012 and P = .020). Transglottic spread significantly decreased time to LF (P = .009). Occult metastatic disease was found in 8.8% of patients undergoing elective neck dissection (END; n = 42, 73.7%), and adjuvant treatment (AT) at time of salvage demonstrated no impact on survival (n = 6, 10.5%).
Conclusions: LVI, positive margins, T4 staging, and transglottic spread are significant poor prognostic indicators. END remains controversial, and AT provided no additional survival benefit. Methods: Systematic review of MEDLINE, Embase, Web of Science, and CENTRAL databases for entries pertaining to physician and public knowledge of HPV infection and its association with OPSCC was performed using the Population, Intervention, Control, Outcome, and Study Design standards.
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Results: A systematic search identified 749 citations. After exclusion criteria and removal of duplicates, 657 abstracts were reviewed, and 33 articles were included in the final analysis. The general population's knowledge of HPV and that HPV is associated with OPSCC ranged from 16% to 75% and from 7% to 57%, respectively. Health care providers' knowledge of HPV ranged from 21% to 84% and that HPV can cause OPSCC ranged from 22% to 100%. Between 33% and 100% of physicians were knowledgeable that HPV can cause OPSCC. The knowledge gap between providers and general population was statistically significant (P < .0001).
Conclusions: HPV education in the general population is statistically less than physicians as well as health care providers. Barriers to improving education of the general population were lack of knowledge and lack of comfort discussing sensitive topics. Stronger advocating of physician education of health care providers and general population is needed to close the education gap of HPV and its association with OPSCC.
Large-cell Neuroendocrine carcinoma Originating in the Subglottic Larynx Jenna V. Van Beck, MD (Presenter); Bin Li, MD; Frank G. Ondrey, MD, PhD
Objectives: To report a case of large-cell neuroendocrine carcinoma originating in the subglottic larynx.
Methods: A case report and literature review are presented.
Results: Neuroendocrine tumors of the larynx are uncommon and heterogeneous, with the rarest form of this tumor being large-cell neuroendocrine carcinoma of the subglottic larynx. We report a case of a 67-year-old man with a primary subglottic large-cell neuroendocrine tumor who presented with a 1-to 2-week history of progressive biphasic stridor and hoarseness. Imaging revealed a subglottic mass with erosion of the cricoid cartilage concerning for malignancy. Diagnosis necessitated an awake tracheostomy and direct laryngoscopy. An ulcerative mass of the left subglottis was biopsied, and final pathology was consistent with poorly differentiated neuroendocrine carcinoma (high-grade and large-cell type). This was based on positivity for synaptophysin, chromogranin, CD56, Ki-67 demonstrating a high proliferation index (>80%), and negative p40 staining. Concurrent chemoradiotherapy resulted in complete radiographic and clinical response at 6 months. We review classification and clinical characteristics of the various subsites.
Conclusions: This is an unusual case of a large-cell neuroendocrine carcinoma of the subglottic larynx. As basaloid squamous cancers are histologically similar to this lesion, the special stains were useful adjuncts. In addition to presenting this case, we highlight the classification and differing characteristics of neuroendocrine tumors of the larynx.
Laryngeal Small-cell Neuroendocrine Tumors: case Series and Experience Kyle S. Kimura, MD (Presenter); Nikita Chapurin, MD; Margaret Mitchell; Young Jun Kim, MD, PhD Objectives: (1) Describe head and neck small-cell neuroendocrine tumors (NETs), which are most commonly located in the larynx. (2) Because there have been only a few reports of the laryngeal small-cell NET subtype in the literature, we aim to present 3 unusual cases of small-cell NETs to raise awareness of this rare and frequently misdiagnosed pathology.
Methods: A retrospective review was conducted between 2015 and 2018 at a major tertiary referral center. All patients were discussed at a multidisciplinary tumor board. Radiographic, pathologic, and oncologic treatment data were reviewed.
Results: All 3 patients were men between age 64 and 73 years with at least a 45-pack-year smoking history. Tumors had positive synaptophysin staining and characteristics of speckled chromatin as well as nuclear molding of small-cell NETs. Most common symptoms included odynophagia and dysphagia. Two of 3 patients had a previous history of laryngeal squamous cell carcinoma (SCC) and had previously undergone chemotherapy or chemoradiation. The patient without a history of laryngeal SCC underwent primary chemoradiation therapy. One patient developed pulmonary metastasis and underwent chemotherapy. Two of 3 patients are still alive and undergoing treatment, and 1 died without any evidence of recurrence.
Conclusions: We present 3 cases of very rare primary smallcell NETs of the larynx and pharynx. Primary chemoradiation therapy has been emerging as the standard of therapy, although surgical resection has a role in treatment in patients with a previous treatment history of SCC.
Late cervical Metastasis of Laryngeal Neuroendocrine Tumors Srinivasa Rao-Merugumala, FRCS, DLO (Presenter); Faiz Tanweer, MBBS, MS(ENT), MRCS; Shri Vishnavi Merugumala
Objectives: To describe 2 cases of rare late presentations of cervical metastasis from the laryngeal neuroendocrine tumors.
Methods: Retrospective case series. An 88-year-old man (case 1) presented with multiple cervical lymph nodes in the
P206
Otolaryngology-Head and Neck Surgery 161(2S) Presentation schedule is subject to change. The Official Program Abstracts supplement does not reflect changes made after August 9, 2019.
HEAd ANd NEck
right side of the neck after 17 years of initial laser resection of the epiglottis for primary neuroendocrine tumor. He underwent right neck dissection levels II, III, and IV as per head and neck MDT. This was histologically confirmed as metastatic neuroendocrine tumor (pN2b). He is now free of disease for 1 year. A 62-year-old woman (case 2) presented with a 2-year history of persistent right-sided odynophagia with referred otalgia and was suspected and treated for glossopharyngeal neuralgia. Microlaryngoscopy showed a cyst over the right arytenoid, which was positive for synaptophysin, chromogranin, and keratin, confirming it as a neuroendocrine tumor. She underwent further wide laser resection. Postoperative magnetic resonance imaging scan of the larynx and positron emission tomography scan were normal. She presented with a right level II neck node after 6 months, which was suggestive of neuroendocrine carcinoma on fine-needle aspiration cytology. She underwent right selective level II neck dissection as per head and neck MDT. She is now free of disease for 1 year.
Discussion: Neuroendocrine neoplasms of the larynx are rare but are the most common nonsquamous tumors. It represents <1% of all primary laryngeal tumors with poor prognosis. The tumor is locally aggressive, painful, and remains dormant for a long duration even after wide resection.
Conclusions: In our case series, patients survived for a longer duration after initial laser resection. Complete clearance with laser can provide local cure, but patients can present with late regional metastasis. Hence, it requires long-term follow-up.
Lipoblastoma of the Parapharyngeal Space:
A case Report Gregory Epps, MD (Presenter); David M. Cognetti, MD; Dylan Roden, MD Objectives: To describe a rare case of lipoblastoma of parapharyngeal space and discuss histopathologic findings and genetic tests needed to confirm its diagnosis.
Results: A 4-year-old girl presented with a left neck mass that was identified on a magnetic resonance imaging (MRI) of her brain that was performed for seizures. She was referred to our department for further management. Further work-up with an MRI of the neck showing a large, heterogeneous, complex left parapharyngeal space mass with multiple cystic and fatty components with mass effect on the oropharyngeal airway. Differential included teratoma or hairy polyp. The patient underwent transoral robotic resection of the left parapharyngeal space mass. The mass was completely excised, and the defect was closed primarily. Final pathology revealed a lipoblastoma. Further genetic testing showed rearrangement of the PLAG1 (8q12.1) locus. Additional copies of chromosome 8, either alone or with rearrangement of the PLAG1 (8q12.1) locus, are the most common numerical change observed in 10% to 15% of patients with a clinical diagnosis of lipoblastoma. The patient did well postoperatively and is currently without issues or deficits.
Conclusions: Lipoblastoma is a rare, benign, soft-tissue tumor found in the head and neck region and confirmed with histopathologic analysis and genetic testing. Once diagnosed, complete surgical resection remains the preferred therapy.
Local Tumor Excision in Treatment of
Nasopharyngeal carcinoma Jamie Reid Oliver (Presenter); Peter S. Wu, MD; Zujun Li, MD; David Schreiber, MD; Kenneth Hu, MD; Luc G. Morris, MD; Babak Givi, MD Objectives: Surgery is rarely used as a modality in treatment of nasopharyngeal carcinoma (NPC). We investigated the National Cancer Database to examine patterns of use and impact of surgery in treatment of NPC.
Methods: We selected all NPC cases between 2004 and 2015 excluding patients who did not receive treatment or who had incomplete data. Cox regression analyses were performed.
Results: A total of 8823 NPC patients were identified. Median age was 54 years. Most were male (6212, 70.4%), white (5008, 56.8%), and presented with advanced-stage disease (III-IV, 5750, 74.8%) and nodal metastases (5873, 75.7%). Distant metastases were rare (730, 8.6%). Most were treated by chemoradiotherapy (CRT; 6478, 73.4%); however, 11.3% (998) were treated by surgery, frequently followed by adjuvant CRT (570, 6.5%) or radiation therapy (RT; 200, 2.3%). Most surgeries were local tumor excisions (744, 79.7%). Negative margins were obtained in 48.5% (291). The 5-year overall survival (OS) rate was 65.2%. In tumors less than 4 cm in size, the addition of surgery with adjuvant RT or CRT was associated with improved overall survival compared with CRT in univariate and multivariable regression (hazard ratio = 0.73; 95% confidence interval = 0.56-0.96, P = .02) controlling for age, sex, race, comorbidities, tumor size, stage, histology, and grade.
Conclusions: Most NPC patients are treated with CRT with good outcomes. The role of local tumor excision is not clear at this time but in a minority of patients is associated with improved survival. This might warrant validation in a prospective clinical trial.
Metastatic cervical cancer in the Neck: A Rare cause of Neck Pain Vyas Prasad, MRCS, DLO (Presenter)
Objectives: To report a case of metastatic cervical cancer in a 50-year-old woman with a sole presentation of neck fullness and ache after close 2-year posttreatment follow-up, and review the literature.
Methods: A case report and review of the literature on isolated bony metastases to the neck from cervical cancer were performed.
Results: A 50-year-old Chinese woman presented with vague symptoms of musculoskeletal ache in both her sternocleidomastoid muscles with no neurological symptoms or
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HEAd ANd NEck signs. She had been treated for stage 2 cervical cancer with chemoradiotherapy 2 years prior and followed up thus far without any signs of recurrence. Her main concern was the possibility of lymph node metastases in her neck, which prompted her visit. She was otherwise fit and well and did not have any abdominal or pelvic issues. Rather than performing an ultrasound scan of her neck, which would have been the first investigation of choice, the author elected to assess her neck using cross-sectional computed tomography (CT) with contrast. Two bony lytic lesions, one in the body of C7 and the other in the lateral process of T1, were identified.
Conclusions: Metastases from the urogynecological tract to the head and neck after successful treatment is rare. The patient was otherwise symptom free and developed a feeling of stiffness, fullness, and musculoskeletal ache on both sides of her neck. The decision to perform a CT scan with contrast was fortuitous in that the metastatic deposits in vertebrae C7 and T1 were picked up. Ear, nose, and throat surgeons should be aware that such a presentation for seemingly unrelated symptoms to cancers of the urogenital tract can in fact be the harbinger for recurrence and consider carefully the investigation of choice in assessing such complaints. Methods: Search strategies were created by a medical librarian, implemented in multiple databases, and completed in November 2018. The population of interest was adults 50 years or younger with no significant tobacco use history (≤10 pack-years) with OCSCC who have had their tumor genetically sequenced or mutational profile analyzed. The search strategy yielded 178 abstracts. Fifty-one studies were screened, leaving 14 articles for review. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed.
Mutations in
Results: Fourteen studies met criteria; all were case-controls, case series, or case reports. The number of young nonsmokers (YNSs) with OCSCC included in each study ranged from 1 to 21. TP53 was the most commonly evaluated gene (9 of 14 studies), and the most frequently seen mutation. Four studies found that nonsmokers had significantly fewer TP53 mutations. Four studies found no difference in the prevalence of TP53 mutations between smokers and nonsmokers. One study found CDKN2A gene mutations only in nonsmokers. No other gene mutation was found to be specific to this patient population.
Conclusions: TP53 mutations may be less common in YNSs with OCSCC. There are few studies with relatively small sample sizes that aim to characterize the genetic landscape of oral cavity tumors in this growing patient population. Future studies are needed to explore unidentified tumor-susceptibility genes or alternative mechanisms of carcinogenesis in this cohort. 
Neutrophil-to-Lymphocyte Ratio as a
extranodal extension (ENE), lymphovascular invasion (LVI), and perineural invasion (PNI).
Results: Linear regression analysis revealed a statistically significant correlation of NLR with pT (P < .001), tumor size (P = .0159), and number of positive lymph nodes (P = .0035) for only the HPV-positive cohort. No statistically significant relationship was seen between NLR and the presence of ENE, LVI, or PNI.
Conclusions: Decreased NLR is associated with smaller tumors, lower pathologic T stage, and fewer positive lymph nodes in OPSCC patients treated with TORS. NLR may represent a novel prognostic indicator with a unique role in HPVpositive disease. Objectives: The incidence of occult metastasis (OM) in laryngeal squamous cell carcinoma (SCC) is still widely debated. In this systematic review, we aim to determine the rate of OM in laryngeal SCC, its impact on recurrence, and the role of elective neck dissection (END) in the management of the clinically N0 (cN0) neck.
Occult Metastasis in Laryngeal Squamous
Methods: Systematic review of the available literature following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Web of Science, PubMed, MEDLINE, and Cochrane databases were queried for Englishlanguage studies published between 1978 and 2018. Studies reporting data on salvage or clinically node-positive patients
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and those without quantitative data on END or rates of OM in patients with laryngeal SCC were excluded.
Results: Twenty-three studies met the criteria for analysis. From a total of 4075 patients, the overall rate of OM was 20.2% across subsites. The supraglottis was found to have a higher incidence of OM (23.9%) compared with glottic tumors (13.2%). Most OMs occurred in patients with T3/T4 tumors (79.9%). Ipsilateral neck disease was found in 79.3% of patients, whereas 20.7% of patients demonstrated bilateral or contralateral disease. Ipsilateral levels IIa (49.7%), III (31.5%), and IV (10.6%) were more commonly affected, and ipsilateral level IIb was frequently spared (1.4%). Recurrence rate between pN+ (43%) and pN-(51%) patients was not statistically significant (P > .05). The overall rate of neck recurrence for END patients was 7.1%, and the 5-year overall survival was 72.9%.
Conclusions: The rate of OM in laryngeal SCC is relatively low. Anatomical subsite and T stage should be considered for indication and level of END. OM appears to have little impact on recurrence. [OPHL] and total laryngectomy). The comparative surgical anatomy and training opportunities on the ovine model are described and discussed.
Open Laryngeal Surgery on
Methods: Experimental creation and validation of a training model for laryngeal surgery in the gross anatomy laboratory and during an international dissection course. We studied the ovine model anatomy and designed specific surgical training for laryngeal surgery. The training model was validated during an international course on laryngeal surgery held at our tertiary care hospital in 2018. All participants were trained in OPHL type 1, 2 a/b, 3 a/b (even with sacrifice of ARY or CAU) and total laryngectomy. After the course, each participant completed a questionnaire to subjectively evaluate the training model on different aspects, rating from 1 (very poor) to 10 (excellent).
Results: We assessed the suitability of the ovine training model among specialized otolaryngologists with a mean experience of 6.9 years. All the surgical procedures were feasible, and specific gestures were coherent with those performed in the human cadaveric dissection and live surgery. Feedback from the participants was very positive, with a mean general impression of 9.6 (out of 10) and a recommendation score of 9.7 for further use.
Conclusions Methods: A retrospective review of patients who underwent orbital exenteration for malignant lesions of the orbit and surrounding structures at UNC from 2009 to 2017 was completed. Primary outcome measures were overall survival and complication rates.
Results: Nineteen patients were selected for review. Eighteen patients had T4 tumors. Only patients with at least 3 months of follow-up were included in the analysis. The most common tumor locations were the orbit, maxillary sinus, and infratemporal fossa. Nine patients (47%) experienced an expected intraoperative cerebrospinal fluid (CSF) leak secondary to skull base, and dural resection and negative margins were achieved in 17 patients. Fifteen patients (79%) received free-flap reconstruction. Most patients (68%) received postoperative adjuvant chemotherapy and/or radiation therapy. One patient experienced a postoperative CSF leak requiring repair, and 1 patient experienced flap breakdown secondary to infection. Patients with basal cell carcinoma, ghost cell odontogenic carcinoma, adenocarcinoma, esthesioneuroblastoma, melanoma, sarcoma, and adenoid cystic carcinoma all had 1-year survival rates of 100%. Squamous cell carcinoma (n = 7, 37%) had a 1-year survival rate of 86%. One patient with sinonasal undifferentiated carcinoma died less than 1 year following surgery. Basal cell carcinoma and odontogenic ghost cell carcinoma had 5-year survival rates of 100%.
Conclusions: Orbital exenteration with free-flap reconstruction is an oncologically sound operation for advanced malignancy of the orbit and surrounding structures.
Pain and Swallow Outcomes after Transoral Robotic Tongue Base Mucosectomy
Daniel Scholfield, MBBCh (Presenter); Andrew Williamson; Zaid Awad, DOHNS, FRCS Objectives: To systematically review the current literature on transoral robotic (TOR) tongue base mucosectomy (TBM) and analyze swallow and pain outcomes for these patients at a United Kingdom tertiary head and neck cancer referral center.
Methods: We undertook a systematic review of the literature on TOR TBM and summarized quality-of-life and morbidity outcomes. We then collected prospective data on a case series of 8 patients at our institution from 2017 to 2018 using the University of Washington Quality of Life Questionnaire (UW-QOL), the MD Anderson Dysphagia Inventory (MDADI), and a chart review. Primary outcomes included
Poster Presentations
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UW-QOL and MDADI scores, time to oral feed, and length of nasogastric (NG) feeding.
Results: After a median of 6 months, median UW-QOL pain and swallowing scores were 100 (range = 75-100) and 72.5 (range = 70-100), respectively. The median MDADI global score was 100 (median emotional score = 93.3; functional = 100; physical = 95). The median time to soft diet postoperatively was 1 day (range = 0-9), and the median length of NG feeding was 0 days (range = 0-15).
Conclusions: Previous studies have shown that swallowing and pain are the most important issues reported by head and neck cancer patients in their treatment. The UW-QOL and MDADI are validated questionnaires specific to head and neck cancer. Until now, pain and dysphagia in TOR TBM have been addressed only as secondary outcomes in the literature. Our data show that post-TBM patients have a highly functional swallow and are pain free at 6 months. Routine insertion of an NG tube is not necessary. These data will help facilitate informed discussions with patients and provide a baseline for future studies into TOR TBM, which is growing in use because of its effectiveness in diagnosing cancer of unknown primary cause.
Parapharyngeal Tumor Presenting with Hypotension Requiring Vasopressor Support Michael H. Freeman, MD (Presenter); James L. Netterville, MD
Objectives: Common poststyloid parapharyngeal space tumors, including paragangliomas, schwannomas, neurofibromas, and neuromas, typically present indolently over months to years. Symptoms typically develop because of compression of local structures, particularly the vagal nerve, sympathetic chain, and carotid body. Sudden presentation and severe symptoms are very rare.
Case description: A 17-year-old girl presented for management of syncope followed by persistent hypotension requiring vasopressor support. Imaging demonstrated a poststyloid parapharyngeal space mass consistent with likely sympathetic schwannoma, and physical examination revealed an ipsilateral Horner syndrome. Urine/plasma metanephrines were normal. A transcervical approach with mass enucleation and sacrifices of the sympathetic trunk was performed. Surgical pathology was consistent with a myofibroma. The patient recovered appropriately without significant sequelae or further hypotension.
Results and discussion: Parapharyngeal space masses have been previously noted in rare cases to cause syncope and transient blood pressure changes likely related to carotid body dysfunction or metanephrine secretion. These changes have not been known to induce hypotension sufficiently severe to require vasopressor support. As the mass did not abut the carotid sinus and the sympathetic chain was deeply involved with the mass sufficiently to require sacrifice during excision, aberrant sympathetic chain signaling may underlie the patient's presentation. In addition, surgical pathology results were highly unusual given the presentation and appearance on imaging. To our knowledge, this is the first case report of a parapharyngeal mass presenting with sudden hypotension requiring vasopressor support.
Parotid Gland Tumors with coincidental Bell Palsy
Lindsay Boven, MD (Presenter); Shehanaz Ellika, MD; Paige Bundrick, MD; Cherie-Ann O. Nathan, MD Objectives: Bell palsy accounts for 75% of sudden facial paralysis. When facial nerve paralysis occurs in the presence of parotid tumors, it is suggestive of malignancy with perineural invasion.
Methods: We report 2 cases of Bell palsy with coincidental parotid tumors but no perineural involvement.
Results: A 58-year-old woman presented with a 3-year history of a right parotid mass and development 2.5 years later of sudden right facial paralysis (House-Brackmann IV). Fineneedle aspiration (FNA) revealed acinic cell carcinoma, and magnetic resonance imaging (MRI) showed a right parotid mass with right facial nerve labyrinthine segment enhancement. The patient underwent a right superficial parotidectomy, and the tumor was not adjacent to the nerve. T2N0M0 acinic cell carcinoma was confirmed histopathologically. Postoperative MRI showed facial nerve enhancement. In addition, an 87-year-old women presented with a 2-year history of a right parotid mass and development 2 years later of sudden total right facial paralysis. FNA showed an oncocytic neoplasm. Computed tomography scan was concerning for perineural spread. The patient underwent right parotidectomy, and the tumor was adjacent to but not infiltrating the nerve. Final pathology of an erythematous buccal branch showed no perineural invasion. Pathology confirmed T2N0M0 malignant oncocytoma with an intact capsule. On 3-year follow-up, both patients' facial paralysis persisted without parotid cancer recurrence.
Conclusions: Facial nerve paralysis was attributed to coincidental Bell palsy in both cases as intraoperative findings and pathology confirmed low-grade tumors, intact capsules, and no nerve involvement. Intraoperative findings can guide facial nerve sacrifice even with facial nerve paralysis in patients with parotid malignancies.
PdL1 Expression with Stage and Histological Grade of Parotid carcinoma
Masaaki Higashino, MD, PhD (Presenter); Shuji Nishikawa; Tetsuya Terada, MD, PhD; Shin-ichi Haginomori, MD; Ryo Kawata
Objectives: The immune checkpoint ligand programmed death ligand-1 (PD-L1) is expressed by various cancers, including those of the head and neck. However, the role of PD-L1 is still unknown in parotid carcinoma.
Methods: PD-L1 expression was investigated by immunohistochemical analysis in 127 patients with parotid carcinoma. The relationship between PD-L1 expression and stage, histological grade, histological type, and survival was assessed.
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Results: PD-L1 expression was found in 28.3% of parotid carcinomas, with the expression being higher in tumors with a higher stage and higher grade and node-positive cases. However, the 5-year disease-specific survival rate was 82.2% and 86.9% for patients with PD-L1-positive and PD-L1-negative tumors, respectively, showing no significant difference. With regard to the histopathological classification, the PD-L1-positive rate was higher in squamous cell carcinoma, salivary duct carcinoma, carcinoma ex pleomorphic adenoma, and mucoepidermoid carcinoma.
Conclusions: PD-L1 expression was positive in approximately 50% of high-grade carcinomas, which was similar to the level in head and neck squamous cell carcinoma. In patients with other cancers, it has been reported that an anti-PD-1 monoclonal antibody was more effective against tumors with higher PD-L1 expression. Therefore, it could be a possible new therapeutic option for patients with highly malignant parotid tumors who have a poor prognosis.
Pleomorphic dermal Sarcoma of the External Auditory canal
Ryan A. Rimmer, MD (Presenter); Dylan Roden, MD; Richard A. Goldman, MD; Adam Luginbuhl, MD Objectives: To describe a rare case of pleomorphic dermal sarcoma of the ear and discuss histopathologic findings to confirm its diagnosis.
Results:
A 73-year-old man presented with a mass of the left conchal bowl and external auditory canal (EAC). A lesion was excised via Mohs surgery from this area 6 months prior with a diagnosis of atypical fibroxanthoma. The lesion recurred after 5 months, and repeat biopsy was consistent with angiosarcoma. He was then referred to our department. On examination, the mass extended to the bony-cartilaginous junction. Magnetic resonance imaging demonstrated a mass with low T1 signal and heterogeneous enhancement, extending into the EAC, but adjacent marrow spaces were clear. On positron emission tomography, the mass had maximum standardized uptake value of 12.6. Two hypermetabolic cervical lymph nodes were identified. The patient underwent auriculectomy with sleeve resection, total parotidectomy, left neck dissection, and reconstruction with an anterolateral thigh-free flap. Final pathology revealed a high-grade spindle cell neoplasm extending focally through underlying hyaline cartilage consistent with pleomorphic dermal sarcoma. Multiple immunohistochemical stains were performed; vascular (CD31, D2-40, and ERG) and melanoma (SOX 10, Melan A, HMB-45, S100 protein) markers were negative. Cervical lymph nodes were negative for metastatic disease. The patient did well postoperatively and is currently undergoing radiotherapy.
Conclusions: Pleomorphic dermal sarcoma is an aggressive, rare mesenchymal tumor that can be difficult to distinguish from other cutaneous pleomorphic spindle cell tumors. Careful histopathologic review and multiple immunohistochemical stains are needed to confirm the diagnosis.
Poor Prognosis of Recurred Masticator Space undifferentiated Pleomorphic Sarcoma
So-Yoon Lee, MD (Presenter); Tae Hyun Shin; Yoon Woo Koh; Ji Eun Park Objectives: Sarcomas make up between 1% and 2% of head and neck tumors, which are a small but significant group of malignancies. The goal of this report is to show the unusual poor prognosis of recurred undifferentiated pleomorphic sarcoma even after successful salvage surgery.
Methods: A 67-year-old female patient had undergone excision via the transparotid approach for the right-side 4-cm masticator space mass 4 years ago at another hospital. It was then diagnosed as a low-grade, fibromyxoid sarcoma with no clear margin. No adjuvant treatment was performed. Three years after the surgery, the mass began regrowing, so radiotherapy was applied as salvage treatment; however, the patient quit the treatment on 16 Gy because of pain and inconvenience. An exophytic mass extended into the masticator, parotid, and buccal spaces. House-Brackmann III facial palsy was noted. Salvage operation and reconstruction were successfully performed.
Results: Excision was completed without any major complication with clear margin. Two types of flap were successfully performed. The patient was able to eat and was satisfied with her features. However, 2 months after the salvage surgery, lung metastasis and primary tumor recurrence were identified. Two months after lung metastasis, the patient died of respiratory failure.
Conclusions: Undifferentiated pleomorphic sarcoma is the most common sarcoma in the head and neck region. Its prognosis is mostly favorable under proper management. Sarcomas can arise because of inherited mutations in tumor-suppressor genes and also because of environmental exposure; the most common environmental etiology is exposure to ionizing radiation. We report poor progress of recurred undifferentiated sarcoma after 16-Gy exposure of radiation therapy.
Predictors of Increased Length of Stay following Parotidectomy
Richard D. Bavier (Presenter); Richard C. Park; Roman Povolotskiy; Lindsay Burke, MD; Peter Ashman, MD; Soly Baredes, MD Objectives: To aid in operative planning by determining predictors of prolonged hospital stay following parotidectomy.
Methods: A retrospective analysis was performed of patients who had parotidectomy surgeries (n = 2645) between 2005 and 2016 identified using the American College of Surgeons National Quality Improvement Program. Cases with predischarge complications were excluded. Multivariable logistic regression was used to determine independent predictors of length of stay exceeding 1 day.
Results: A total of 2645 patients were identified; 24.8% were discharged the same day, 46.3% after 1 day, and 28.9% after more than 1 day. Prolonged length of stay was defined as greater than 1 day. Multivariable logistic regression identified Patients who had a length of stay exceeding 1 day had higher rates of postdischarge complications (21.2% vs 3.0%, P < .001) and unplanned readmission (8.0% vs 0.9%, P < .001).
Conclusions: Comorbidities and perioperative factors associated with increased length of stay following parotidectomy were identified. These results can help guide preoperative evaluation and postoperative planning and care to help reduce average length of stay.
Predictors of Stricture and Swallowing Function following Salvage Laryngectomy
Ari D. Schuman (Presenter); Andrew C. Birkeland, MD; Janice Farlow, MD; Teresa Lyden, MA, CCC-SLP; Matthew E. Spector, MD; Andrew J. Rosko, MD
Objectives: Long-term functional outcomes are poorly characterized for salvage laryngectomy. We sought to identify predictors of esophageal stricture and swallowing function in a large cohort after salvage laryngectomy.
Methods: A retrospective cohort study of 339 patients who underwent salvage laryngectomy between 1997 and 2016 for recurrent/persistent squamous cell carcinoma of the larynx or hypopharynx after radiation therapy (XRT) or chemoradiation was performed. The primary outcomes were rate of esophageal dilation within 1 year, ability to take an oral diet, and time to first dilation. Bivariate, multivariable logistic, and Cox regressions were performed.
Results: In total, 27% of patients required dilation. Of these, 69% required dilation within 1 year after surgery. In the multivariable analysis, patients with a fistula were 1.9 times more likely to require dilation in the first year (P = .04). The number of dilations increased as the interval between XRT and salvage surgery increased (hazard ratio per month 1.006, P = .02). Patients with recurrent glottic tumors were 1.3 times more likely to take an oral diet compared with those with hypopharyngeal tumors (P = .01). Patients who never used alcohol were 2 times more likely to take an oral diet compared with alcohol users at the time of salvage (P = .03).
Conclusions: Fistula was associated with stricture formation in the first year after salvage laryngectomy. Hypopharyngeal subsite and alcohol use were each associated with poor swallowing outcomes. Methods: A case presentation and review of the literature are described.
Primary Merkel cell carcinoma of the
Results: A 60-year-old male smoker presented with a 1-week history of a left neck mass. Examination revealed a conglomeration of lymph nodes extending throughout left levels II-V. Flexible laryngoscopy demonstrated a vallecular mass crossing midline and extending onto the lingual surface of the epiglottis. Fine-needle aspiration of the neck mass was consistent with poorly differentiated carcinoma with neuroendocrine features suspicious for Merkel cell carcinoma. Positron emission tomography/computed tomography demonstrated marked hypermetabolic activity in the left neck and right scapula and uptake in the ribs, spine, and pelvis concerning for skeletal metastases. Direct laryngoscopy demonstrated an ulcerative mass involving the entire vallecula down to the hyoepiglottic ligament and diffuse abnormal tissue along the epiglottis. Pathology was consistent with high-grade neuroendocrine carcinoma favoring Merkel cell carcinoma. Ultrasound-guided core biopsy of the right scapular region revealed poorly differentiated carcinoma with neuroendocrine features. Full dermatologic evaluation yielded no evidence of skin lesions concerning for a primary Merkel cell carcinoma. The patient was initiated on immunotherapy but ultimately demonstrated local tumor progression requiring urgent tracheostomy for the rapidly expanding neck and vallecular masses.
Conclusions: Merkel cell carcinoma typically exhibits a propensity for the skin and soft tissue, and primary mucosal Merkel cell carcinoma with regional and skeletal metastases is exceedingly rare. Otolaryngologists should be knowledgeable of this atypical presentation to prevent diagnostic and therapeutic misadventure. Objectives: Sebaceous carcinoma can originate from any sebaceous gland, most commonly from the eyelid in association with meibomian glands or glands of Zeis. Other subsites of the head and neck are rarer and have yet to be thoroughly described. Database studies focusing on noncutaneous sebaceous carcinoma are needed and may serve as a resource when these tumors are encountered.
Primary Salivary Gland Sebaceous
Methods: The National Cancer Institute's 18-registry Surveillance, Epidemiology, and End Results (SEER) database was investigated. Cases of primary major or minor salivary and lacrimal sebaceous carcinoma (International Classification of Diseases for Oncology-3 8410) between 1973 and 2015 were included. Demographic information, age at diagnosis, histologic data, and overall survival were reviewed.
Results: A total of 22 cases of salivary and lacrimal sebaceous carcinoma were identified. There was a male predominance (68.2%) and mean age at diagnosis of 64.2 years. The parotid gland comprised 77.3% of primary tumors. There was 1 submandibular gland tumor. No cases of minor or sublingual
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Conclusions: A review of the SEER database revealed that primary sebaceous adenocarcinoma of the salivary and lacrimal glands is exceptionally rare, with only 22 cases recorded. Most of these patients presented with poorly differentiated subtypes. This information may have utility in counseling patients and managing expectations when this diagnosis is encountered in clinical practice.
Problems Swallowing for Head and Neck cancer Survivors Li-Jen Liao, MD (Presenter)
Objectives: Head and neck cancer (HNC) is one of the most common cancers worldwide. The therapy of HNC is associated with acute and late swallowing dysfunction. The goals of this study are to assess the prevalence and related risk factors of problems with swallowing for HNC survivors.
Methods: This is a prospective cross-sectional study conducted from March 2017 to June 2017 in a medical center in Taiwan. A total of 212 cancer survivors were recruited and assessed using the Eat Assessment Tool (EAT)-10 score. If the EAT-10 score was greater than 3, patients were regarded as having problems with swallowing. Logistic regression was used to evaluate the significance between risk factors of interest and problems with swallowing.
Results: A total of 58 female and 154 male patients (mean age 56.3 ± 10.3 years) completed the EAT-10 questionnaire. The EAT-10 score was 6.3 ± 9.2 (mean ± standard deviation) for these patients. A total of 154 patients (73%) had an EAT-10 score greater than 3. Oropharyngeal cancer and aggressive treatment (surgery combined with concurrent chemoradiotherapy [CCRT]) led to a higher risk (71% and 59%) of swallowing dysfunction. The adjusted logistic regression showed that those with oropharyngeal cancer had 9.62 times the risk of problems with swallowing compared with patients with thyroid cancer (95% confidence interval = 1.4-66). Another factor was surgery combined with CCRT (odds ratio = 3.6, 95% confidence interval = 1.3-9.1).
Conclusions: A high proportion (73%) of HNC survivors have problems swallowing. Oropharyngeal cancer and aggressive treatment may lead to a higher risk of swallowing dysfunction. Objectives: Racial disparities in head and neck cancer survival remain an ongoing challenge. Although it is well recognized that this occurs in tobacco/alcohol-related cancers, it is not clear whether outcome disparities persist in human papillomavirus (HPV)-positive oropharynx cancer (OPC) for which survival is much improved. Our goal was to determine whether outcome disparities in HPV-positive OPC persist, despite the significantly improved survival rate.
Racial disparities in Human
Methods: The National Cancer Database (NCDB) was queried for oropharyngeal squamous cell carcinomas diagnosed between 2010 and 2015 where HPV data are available. We examined stage, race, treatment, HPV status, and demographic data to correlate these factors with survival.
Results: Although 70% of white patients were reported to be HPV positive, only 46% of blacks were reported to be HPV positive. A total of 20,113 HPV positive OPC cases were included for analysis. A significant difference in survival was noted by race, with blacks having a higher risk of death (hazard ratio = 1.4; P < .05). The 2-year survival was 91% vs 86% in whites and blacks, whereas the 5-year survival was 80% vs 74%. This significant difference was still noted when controlling for tumor stage and sex. Further analysis will examine the socioeconomic, comorbidity, and demographic factors that contribute to this disparity.
Conclusions: Despite overall favorable outcomes, a significant difference in survival by race is observed in HPV-positive OPC. Further analysis will need to be performed to better identify factors that may explain this health disparity. Objectives: To determine clinical outcomes of radiotherapy (RT) for locoregional (LR) disease in primary metastatic nasopharyngeal carcinoma (pmNPC) patients.
Radiotherapy to Locoregional disease in
Methods: A retrospective chart review of 62 patients with pmNPC treated at a single tertiary institution was performed. A total of 29 patients received head and neck irradiation after induction chemotherapy. Patient, disease, and treatment data were analyzed. Patients were stratified according to risk using a previously validated clinical prognostic score (based on Eastern Cooperative Oncology Group, hemoglobin level, lactate dehydrogenase, presence of multiorgan metastases). For survival, univariate analysis was done with the Kaplan-Meier method and multivariable analysis with the Cox proportional-hazards model.
Results: The cohort's median overall survival (OS), distant progression-free survival (D PFS), and LR PFS were 18.4, 12.4, and 47.2 months, respectively. In the RT group, these were 23.2, 18.8, and 69.6 months, respectively. In the no RT group, these were 14.0, 10.0, 16.9 months, respectively. The RT group had significantly longer LR PFS (P = .005) but not OS (P = .147) or D PFS (P = .089). Multivariable analysis showed that RT for LR disease was an independent positive prognostic factor for LR PFS but not for D PFS or OS. Stratifying patients based on their prognostic risk score Presentation schedule is subject to change. The Official Program Abstracts supplement does not reflect changes made after August 9, 2019.
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Risk Factor for cerebrospinal Fluid Leak after Endoscopic Endonasal Skull Base Surgery
Hiroyuki Ozawa (Presenter); Mariko Sekimizu; Nana Nakahara; Shin Saito; Shintaro Nakamura; Masahiro Toda; Kaoru Ogawa, MD Objectives: One of the major complications for endoscopic endonasal skull base surgery (EESBS) is a postoperative cerebrospinal fluid (CSF) leak. Nasoseptal flap (NSF) has been proved to prevent CSF leakage, but we have still experienced this complication. This study aimed to evaluate the CSF leakage rate after EESBS in our institution and to assess the influencing factors causing postoperative CSF leak.
Methods: Retrospective analysis of clinical records receiving EESBS from 2012 to 2017 in our institution was conducted.
Results: In a total of 230 EESBSs, 11 cases (4.8%) had suffered from postoperative CSF leakage. The rate of CSF leakage was 3.1%, 3.6%, and 8% for pituitary adenoma with Rathke cleft cyst, chordoma, and meningioma, respectively. Both epidermoid tumor (5 cases, 60%) and craniopharyngioma (2 cases, 50%) were small but had a high risk of postoperative CSF leakage. After NSF reconstruction, postoperative CSF leak rate was 9% (8 cases). Previous surgery more than 3 times was a risk factor for CSF leakage (27% and 3%), but prior radiotherapy and preexisting diabetes mellitus were not associated with CSF leakage. Multivariable analysis revealed that tumor pathology (epidermoid tumor and craniopharyngioma) and extended sellar approach were significant risk factors.
Conclusions: The rate of CSF leakage in this study was comparable with previous reports. Repeated surgical treatment might influence the postoperative CSF leakage rate. Operative strategy including skull base reconstruction method should be considered substantially depending on tumor pathology, surgical procedure, or degree of CSF leak. Methods: In the adult population, there is scant evidence regarding management of scrofula due to mycobacterial infection other than Mycobacterium tuberculosis. The pediatric literature provides some guidance suggesting that infections of this type are best treated with surgery and multidrug therapy. Herein, we report a unique case of an adult patient who developed a fistulous scrofula secondary to M kansasii infection.
Scrofula from Nontuberculosis
Results: A 29-year-old woman presented with a large, tender neck mass of 2 weeks' duration refractory to outpatient antibiotic treatment. Computed tomography (CT) scan revealed evolving fluid collection with infiltration of the sternocleidomastoid muscle. She was found to have human immunodeficiency virus). Incision and drainage of the neck abscess was performed, and cultures grew M kansasii. She was treated with a multidrug regimen; however, the neck mass persisted. Repeat CT scan revealed phlegmon changes and early abscess along the cutaneous fistula tracts. Consequently, she was taken to the operating room for complete excision with neck dissection.
Conclusions: To our knowledge, this represents the first reported case of scrofula due to M kansasii in an adult patient. This patient received multidrug therapy as well as complete surgical excision with neck dissection. With guidance from the pediatric literature, we present our management of this patient and believe further discussion is warranted regarding treatment options for this rare and potentially devastating condition.
Shear-Wave Elastography Is an Independent
Sono-predictor in cervical Lymph Node Wu-chia Lo, MD (Presenter); Po-Wen Cheng, MD; Li-Jen Liao, MD Objectives: The purpose of this study is to assess the diagnostic performance of shear-wave elastography (SWE) compared with the old prediction model using traditional ultrasound (US) in predicting malignant cervical lymph nodes (LNs).
Methods: A total of 109 consecutive adult patients who underwent conventional gray-scale US, color Doppler US, and SWE before US-guided needle biopsy were analyzed. The optimal cutoff values of elasticity indices (EIs) for predicting malignancy were determined by receiver-operating characteristic (ROC) curves. The performance of SWE in the diagnosis of malignant nodes was tested by logistic regression models and was compared with previously proposed model. The c-statistic, net reclassification improvement (NRI), and integrated discrimination improvement (IDI) were used to compare the extended prediction model (SWE + traditional model) with the traditional prediction model.
Results: Malignant LNs had higher EIs (66.3 ± 24.3 kPa) than benign nodes (41.4 ± 26.5 kPa; P < .01). The optimal cutoff point of EI was 42 kPa, corresponding to a sensitivity of 83.3%, specificity of 64.7%, positive predictive value of 40.0%, negative predictive value of 93.2%, and overall accuracy of 68.8%. A multivariable logistic regression analysis confirmed that an EI ≥42 kPa was an independent predictor for malignancy (odds ratio [OR] = 9.86; 95% confidence interval [CI] = 1.82-53.4, P < .01). In the new extended prediction model, SWE had a positive NRI (OR = 0.96; 95% CI = 0.54-1.33) and IDI (OR = 0.10; 95% CI = 0.003-0.26) for predicting malignant neck LNs.
Conclusions: This study shows that SWE can be considered as an adjuvant quantitative tool beyond conventional US. Results: A total of 809 parotidectomies were performed. Mean patient age was 56.8 years (standard deviation [SD] = 16.4). Most patients had benign tumors (n = 577, 71.3%). Among these patients, most had primary salivary gland tumors (95.7%) vs recurrent disease (4.3%). Partial parotidectomy was commonly performed (76.0%), and selective facial nerve branch sacrifice was rare (3.81%). Among patients with intact nerve, 1.5% had long-term facial weakness. The mean operative time was 177.1 minutes (SD = 57.3), decreasing from 271 minutes in 2002 to 93 minutes in 2018 (P < .0001). A total of 232 patients (28.7%) had malignant tumors, including primary salivary malignancy (49.1%), metastasis (44.8%), or other malignancy (6.0%). The most common approach was partial (53.9%) or total (39.7%) parotidectomy. Anterograde nerve dissection was commonly performed (87.9%). Facial nerve sacrifice was rare (35.3%). Among patients with intact nerve, long-term facial weakness was rare (4%).
Single-Surgeon Academic center
Conclusions: Review of this large, academic, single-surgeon series on parotidectomy provides insight into the pathology, long-term facial nerve outcomes, and feasibility of performing a nuanced operation in an academic environment. In addition, we tried to show altered canonical pathways of HPV-positive heavy smokers that were missed or newly developed when compared with those of HPV-positive HNSCCs with better prognosis.
Smoking Effect on
Methods: We downloaded and analyzed gene expression data and clinical data of 270 HNSCC patients from the Gene Expression Omnibus database (GSE65858) to assess the difference of altered canonical pathways in HPV-positive HNSCCs patients with heavy smoking.
Results: When we evaluated the effect of smoking on survival result in HNSCCs, there was no statistically significant difference between heavy smokers and nonsmokers (P = .618), even though heavy smoking showed altered canonical pathways related with aggressive behavior. Interestingly, in HNSCCs patients with heavy smoking, HPV positivity did not show any survival advantage when compared with HPV negativity. With ingenuity pathway analysis, we discovered 46 missed and 103 newly developed canonical altered pathways in heavy-smoking patients with HPV-positive HNSCCs.
Conclusions: In HNSCC patients with heavy smoking, HPV positivity did not show any survival advantage when compared with HPV negativity. Objectives: The goal to personalize oncology treatment has led to the investigation of hundreds of biomarkers that may predict outcome and guide therapy. The objective of this study is to perform a systematic review to summarize the association of protein biomarkers with survival outcomes in patients with newly diagnosed head and neck squamous cell carcinoma.
Systematic Review of Protein Biomarkers in
Methods: Online databases were queried using appropriate search terms. Two independent reviewers reviewed abstracts for inclusion, and data were extracted from included articles. Primary outcome measures were the hazard ratio (HR) associated with overall survival, disease-free survival, diseasespecific survival, and/or progression-free survival. A weighted linear mixed-effects regression model was used to estimate the pooled effect size for each biomarker.
Results: Preliminary results of 100 papers identified 18 studies in which a protein biomarker and associated HR for a survival measure were reported. The only biomarker noted in more than 1 study and available for preliminary analysis was p16 (4/18 studies). Pooled analysis of 4 articles that examined multiple primary sites showed an HR of 0.28 (95% confidence interval = 0.15-0.51) for disease-specific mortality (P = .001). Our preliminary results indicate a wide variety of protein biomarkers under investigation with limited consistent reporting of outcome measures. The full review of 1800 papers that will be completed prior to presentation will summarize the survival association of all protein biomarkers reported in more than one paper for which HRs are reported.
Conclusions: These results should guide further research and encourage standardized reporting of results.
Systematic Review of Submental Island Flap for Reconstruction in Oral cancer
Manish Shaha, MD (Presenter); Brent A. Chang, MD Objectives: The submental island flap (SMI) has gained favor over the past 25 years among head and neck surgeons for coverage of defects after cancer ablation. Use of SMI for intraoral malignancy remains controversial because of the theoretical
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risk of cancer seeding with tissue transfer and pedicle in level 1 of the neck. We seek to describe the oncologic safety, low risk, and versatility of the SMI in oral cavity postablation defects.
Methods: A systematic review of English-language literature was performed for prospective and retrospective studies that described use of SMI in human patients with oral cavity cancer. Each study reported oncologic outcomes including local and nodal recurrence. A comprehensive search of MEDLINE, Embase, and Web of Science was performed.
Results: Ten studies including prospective trials and retrospective reviews were analyzed. A total of 485 SMIs were attempted for coverage of different oral cavity defects. All studies focused on just the SMI; however, 1 study did compare SMI with radial forearm free flaps as a case control. Total flap failure was noted in 13 patients (2.7%). Recurrence during follow-up was seen in 77 cases (15.9%). Local recurrence was reported in 42 patients (8.7%), whereas nodal recurrence was noted in 32 patients with some overlap of these groups. Other surgical complications included partial flap loss, marginal mandibular nerve palsy, hematoma, and persistent intraoral hair growth, all of which resolved with conservative management and/or after adjuvant radiation therapy. Donor site morbidity and functional outcomes were excellent in all cases reported.
Conclusions: The SMI is a well-tolerated and oncologically sound pedicled flap for coverage of oral cavity cancer defects. Methods: A search of the MEDLINE, Embase, and clinicaltrials.gov databases was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Given the absence of prospective trials, the review includes institutional case reports and case series from the period of 1985 to 2018 in the English-language literature. Only cases of esophageal/pharyngeal perforation in the setting of anterior cervical hardware were considered for study inclusion. For purposes of this study, treatment success is defined as resumption of oral intake.
Results: The database review identified 133 distinct series that meet the criteria for study inclusion. Final analysis of data is ongoing. Throughout the period of interest, different treatment options have been used for esophageal/pharyngeal perforation after ACDF ranging from observation to complex free-tissue reconstruction plus removal of hardware. Varying treatment success rates are reported.
Conclusions: Esophageal/pharyngeal perforation after ACDF is a rare but serious complication without a definitive algorithm for treatment. Our systematic review endeavors to define the varied treatment options for this disease process. For most cases, successful treatment requires drainage of purulent discharge, debridement of nonviable tissue, and closure of the site with either primary or a reconstructive procedure. Given the rare nature of this problem, questions remain with regard to the ideal treatment approach, which could likely be answered only with a prospective multi-institutional study.
Thermographic Monitoring of Laser Sialendoscopic Lithotripsy
Alexandros Delidis, MD (Presenter); Aggelos Chatziavramidis; Theodoros Samaras, PhD; Iordanis Konstantinidis
Objectives: To assess the temperature values at the site of lithotripsy during Ho-YAG laser intracorporeal sialendoscopic lithotripsy with the use of an infrared camera. To investigate if different Ho-YAG laser parameters result in thermal injury to the surrounding tissue and a secondary stenosis. These are preliminary results.
Methods: Twelve patients underwent laser lithotripsy for parotid stones of 0.8-to 1.3-mm size within a period of 2 years. The Ho-YAG laser settings during the temperature measurements were 3, 4, and 5 W (0.5-0.8 J). An i3 infrared camera (FLIR Systems, Inc, Wilsonville, Oregon) was used for acquiring the images of the patient extracorporeally. The camera has a thermal sensitivity of 0.15°C. During sialendoscopy, constant flow of saline was achieved with a syringe pump at operating room temperature (22°C).
Results: Thermographic measurements presented a clear image of the parotid ductal system. Continuous thermographic measurements at this time while the laser was operating did not reveal any increase of temperature around the laser tip that could cause tissue damage. All temperature measurements at the surface of the skin above the laser tip ranged between 34°C and 37°C. Follow-up sialendoscopy 6 months later revealed patent ductal system in 5 patients, mild stenosis in 5 patients, moderate but asymptomatic stenosis in 1 patient, and moderate stenosis in 1 patient with some mild transient episodes of sialadenitis postoperatively.
Conclusions: Extracorporeal infrared imaging did not reveal any thermal injury. Postoperatively, some patients still develop stenosis due to mechanical injury or undetected thermal injury at the level of the ductal lining. However, the stenosis in most cases had no clinical significance.
Tissue Engineering the Larynx: Effect of decellularization on Human Larynx
Zaid H. Al-Qurayshi, MBChB, MPH (Presenter); Henry T. Hoffman, MD; Kristi E. Chang, MD; Salem Aliasger Objectives: Assess the effect of decellularization on human cadaveric larynx with analysis of impact on cricoarytenoid joint motion as a preparatory step for whole larynx regeneration.
Methods: Human larynges were decellularized using a previously published protocol.
Poster Presentations
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Results: Two adult male and 3 adult female larynges were compared before and after decellularization. Microscopy using hematoxylin and eosin stain demonstrated substantial removal of cells with preservation of extracellular matrix that was more evident in cartilage than in muscle specimens. Confocal microscopy using Live/Dead stain also demonstrated almost complete removal of cells. Microcopy studies were quantified by measuring DNA quantity. Predecellularization cartilage-DNA quantity range was 27.0 to 336.8 ng per mg, whereas the postdecellularization DNA quantity range was 0 to 30.4 ng per mg (P = .031). For muscles, the predecellularization DNA quantity range was 150.0 to 3384.6 ng per mg, whereas the postdecellularization DNA quantity range was 0 to 45.5 ng pre mg (P = .031). Microcomputed tomography (µ-CT) demonstrated preservation of the cartilaginous framework with a slight reduction of cricoarytenoid joint space. µ-CT demonstrated no significant reduction in Hounsfield unit (P = .25) and mineral density (P = .25) after decellularization. Biomechanical testing demonstrated a nonsignificant reduction of forces required for anterior displacement of the arytenoid (mean reduction of forces, 0.1 ± 0.2 N, P = .16) and of forces required for posterior displacement of the arytenoid (mean reduction of forces, 0.2 ± 0.3 N, P = .05).
Conclusions: This study demonstrates effective decellularization of the human larynx evident by DNA depletion with preservation of extracellular matrix. The decellularization process caused no stiffening of the cricoarytenoid joints, supporting examining the impact of recellularization.
Treatment of Multiple Parotid Strictures: Sialendoscopic double Stenting
Tobias Kleinjung, MD (Presenter); Francis Marchal, MD Objectives: Strictures in the ductal system of parotid glands are one the most common causes of swelling or sialadenitis. We differentiate unique local strictures from multiple strictures. Multiple strictures have a systemic etiology such as Sjögren syndrome, other immunological disorders, or radioiodine-induced sialadenitis. Assessment of strictures can be obtained by ultrasound, magnetic resonance imaging (MRI) sialography, or diagnostic sialendoscopy. The classical treatment is stricture dilatation under vision followed by stenting of the duct. However, if strictures are present in multiple branches, there is a necessity of separate stenting to allow patency after dilatation and to avoid exclusion and postoperative swelling in the excluded parts of the parotid gland.
Methods: A 55-year-old white woman reported recurrent bilateral swelling of the parotid glands that could mainly be managed by self-massage. However, in the past 2 years, she suffered from 3 episodes of acute parotitis, which required the use of antibiotics. Preoperative diagnostic evaluation with ultrasound and MRI sialography revealed bilateral Stensen megaduct with multiple strictures in the intraparotideal branches. A minimally invasive sialendoscopic procedure was performed with visible dilatation of strictures and insertion of 2 silicone stents per side in the main branches of the ductal system. The correct position of the stents was controlled ultrasonographically.
Results: The stents were removed after 2 weeks. After 1 year, the patient is symptom free with very rare and shortlasting swellings. Ultrasound revealed a stable situation of dilated strictures.
Conclusions: For the first time we present a novel, successful technique of double-stent insertion in the parotid gland after stricture dilatation. Objectives: Follicular dendritic cell sarcoma (FDCS) is an exceedingly rare malignancy of the antigen-presenting cells of the immune system, with fewer than 500 cases reported in the literature. An even smaller portion of these cases present extranodally. We present here an unusual case of FDCS of the tonsil.
An unusual case of Follicular dendritic cell
Methods: A case of a single patient with FDCS diagnosed and treated at the Michael E. Debakey Veterans Affairs Medical Center in Houston, Texas, is presented here along with a review of the literature.
Results: A 71-year-old man with 50-pack-year smoking history presented with 2 years of dysphagia and 35-pound weight loss. Examination revealed a 4-cm ulcerative left tonsil mass, without extension to the base of tongue on flexible laryngoscopy. Computed tomography imaging revealed a partially necrotic mass centered in the left tonsil with local invasion into the soft palate without clinically evident lymphadenopathy. Biopsy and immunohistochemistry confirmed FDCS. The patient underwent a left radical tonsillectomy with partial pharyngectomy, left selective neck dissection, and forearm free-flap reconstruction with tracheotomy and G tube. He recovered well and was decannulated on postoperative day 7. Postoperative modified barium swallow revealed no evidence of aspiration or fistula, and he began a soft diet. He underwent adjuvant radiation and currently remains without clinical evidence of recurrence.
Conclusions: Extranodal FDCS is a rare malignancy. Surgery remains the mainstay of treatment, with adjuvant therapy indicated if adverse pathological features are present. Greater awareness of the clinical and histopathologic features of FDCS is warranted given its potential for recurrence and metastasis. 
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malignancies, such as Merkel cell carcinoma and adnexal primaries, can be also encountered. These tumors typically involve only the soft tissues of the scalp, but bone invasion can sometimes occur. We present a case of scalp malignancy with unusual pathology. An 84-year-old woman presented to the emergency department with hypertensive crisis. On physical examination, there was a firm, nontender right parietal scalp mass. A computed tomography of the head without contrast revealed a large, heterogeneous soft-tissue abnormality along the right parietal scalp that appeared to invade the adjacent bone, measuring 3.6 × 4.7 × 2.8 cm. A brain magnetic resonance imaging revealed a 5.1-cm mass in the superior right scalp extending through the parietal calvarium to the right brain, with concern of invasion into the adjacent superior sagittal sinus. An incisional biopsy pathology showed poorly differentiated carcinoma, suspicious for metastasis. A positron emission tomography/computed tomography image was subsequently obtained to assess for the primary site, but there were no other sites of disease. After discussion with the pathologist, it was felt this was most likely a primary adnexal adenocarcinoma. She underwent a radical resection of the scalp with partial craniectomy, dural resection, titanium plate cranioplasty, and latissimus dorsi free-flap reconstruction. Final pathology revealed an anaplastic meningioma (World Health Organization grade III). The differential for malignant scalp masses are typically cutaneous, which can erode the bone, but invasion is typically limited and extremely rare for intracranial extension. In this case, the extensive intracranial disease is unusual and should have raised the possibility of an intracranial primary.
